Skip to main content

Need urgent help? Start triage first, then route to emergency care.

Start symptom intake Emergency vets near you

Meds A-Z

Neomycin Sulfate

Detailed information about Neomycin Sulfate

Official label facts Owner quick guide first Marketing clearly labeled
Talk to a Vet / Find a Vet Near You Start Symptom Intake
Showing simplified owner view. Switch to Vet View for full technical detail.

Pet Owner Quick Guide

Start here: what this medicine is for, what it does, and when it's usually needed.

Usually used for:

For control of chronic respiratory disease (CRD) and air sac infection caused by Mycoplasma gallisepticum and Escherichia coli susceptible to oxytetracycline.

What it does:

It is indicated for treating acute otitis externa and, to a lesser degree, chronic otitis externa in dogs. In treatment of ear canker and other inflammatory conditions of the external ear canal. It is indicated for treat...

When it's needed:

Tetracaine and neomycin have the potential to sensitize. Care should be taken to observe animals being treated for evidence of hypersensitivity or allergy to the product. If such signs are noted, therapy with the product...

Call your vet sooner if you notice:

  • Tetracaine and neomycin have the potential to sensitize. Care should be taken to observe animals being treated for evidence of hypersensitivity or allergy to the product. If such signs are noted, therapy with the product should be stopped. Incomplete response or exacerbation of corticosteroid responsive lesions may be due to the presence of non susceptible organisms or to prolonged use of antibiotic-containing preparations resulting in overgrowth of non susceptible organisms, particularly Monilia. Federal law restricts this drug to use by or on the order of a licensed veterinarian. Add to drinking water. Not for use in liquid supplements. Prepare a fresh solution daily. If symptoms persist after using this preparation for 2 or 3 days, consult a veterinarian. Treatment should continue 24-48 hours beyond remission of disease symptoms, but not to exceed a total of 14 days. Discontinue treatment 1 day prior to slaughter in cattle. A withdrawal period has not been established for use in preruminating calves. Do not use in calves to be processed for veal. Use of more than one product containing neomycin or failure to follow withdrawal times may result in illegal drug residues. Add to drinking water. Not for use in liquid supplements. Prepare a fresh solution daily. If symptoms persist after using this preparation for 2 or 3 days, consult a veterinarian. Treatment should continue 24-48 hours beyond remission of disease symptoms, but not to exceed a total of 14 days. Discontinue treatment 2 days prior to slaughter in sheep. Use of more than one product containing neomycin or failure to follow withdrawal times may result in illegal drug residues.

Commonly reported reactions:

  • (1 reports)
  • (1 reports)
  • (1 reports)

What to ask your vet today:

  • Is this medicine the right fit for my pet’s current symptoms?
  • Which warning signs mean I should call back right away?
  • How should I handle missed doses or refusal to take the medicine?
Talk to a Vet / Find a Vet Near You
Image coming soon
Neomycin Sulfate

Neomycin Sulfate

Drug type: Generic ingredient • Branded profile • FDA branded products available

Species: Both

Manufacturer: Zoetis Inc.

Quick Facts

Official label facts first, then secondary summaries. Marketing content is separated below.

Species: Both
Manufacturer: Zoetis Inc.
Form: Cream, Liquid, Liquid (Solution), Liquid (Suspension), Ointment, Powder
Identifiers:
ANADA: 200046 ANADA: 200050 ANADA: 200113 ANADA: 200118 ANADA: 200130 ANADA: 200153 ANADA: 200235 ANADA: 200245 ANADA: 200289 ANADA: 200330 ANADA: 200378 ANADA: 200379 ANADA: 200553 ANADA: 200565 NADA: 10524 NADA: 11315 NADA: 11437 NADA: 11703 NADA: 11953 NADA: 12258
Source metadata:

Warnings / Contraindications

Tetracaine and neomycin have the potential to sensitize. Care should be taken to observe animals being treated for evidence of hypersensitivity or allergy to the product. If such signs are noted, therapy with the product should be stopped. Incomplete response or exacerbation of corticosteroid responsive lesions may be due to the presence of non susceptible organisms or to prolonged use of antibiotic-containing preparations resulting in overgrowth of non susceptible organisms, particularly Monilia. Federal law restricts this drug to use by or on the order of a licensed veterinarian. Add to drinking water. Not for use in liquid supplements. Prepare a fresh solution daily. If symptoms persist after using this preparation for 2 or 3 days, consult a veterinarian. Treatment should continue 24-48 hours beyond remission of disease symptoms, but not to exceed a total of 14 days. Discontinue treatment 1 day prior to slaughter in cattle. A withdrawal period has not been established for use in preruminating calves. Do not use in calves to be processed for veal. Use of more than one product containing neomycin or failure to follow withdrawal times may result in illegal drug residues. Add to drinking water. Not for use in liquid supplements. Prepare a fresh solution daily. If symptoms persist after using this preparation for 2 or 3 days, consult a veterinarian. Treatment should continue 24-48 hours beyond remission of disease symptoms, but not to exceed a total of 14 days. Discontinue treatment 2 days prior to slaughter in sheep. Use of more than one product containing neomycin or failure to follow withdrawal times may result in illegal drug residues.

  • High: Tetracaine and neomycin have the potential to sensitize. Care should be taken to observe animals being treated for evidence of hypersensitivity or allergy to the product. If such signs are noted, therapy with the product should be stopped. Incomplete response or exacerbation of corticosteroid responsive lesions may be due to the presence of non susceptible organisms or to prolonged use of antibiotic-containing preparations resulting in overgrowth of non susceptible organisms, particularly Monilia. Federal law restricts this drug to use by or on the order of a licensed veterinarian. Add to drinking water. Not for use in liquid supplements. Prepare a fresh solution daily. If symptoms persist after using this preparation for 2 or 3 days, consult a veterinarian. Treatment should continue 24-48 hours beyond remission of disease symptoms, but not to exceed a total of 14 days. Discontinue treatment 1 day prior to slaughter in cattle. A withdrawal period has not been established for use in preruminating calves. Do not use in calves to be processed for veal. Use of more than one product containing neomycin or failure to follow withdrawal times may result in illegal drug residues. Add to drinking water. Not for use in liquid supplements. Prepare a fresh solution daily. If symptoms persist after using this preparation for 2 or 3 days, consult a veterinarian. Treatment should continue 24-48 hours beyond remission of disease symptoms, but not to exceed a total of 14 days. Discontinue treatment 2 days prior to slaughter in sheep. Use of more than one product containing neomycin or failure to follow withdrawal times may result in illegal drug residues.
Source metadata:

Adverse Reactions

Snapshot first, detailed rows second. This section summarizes signal data and is not a diagnosis.

Tap or hover a reaction to see what it means in plain language.

Tracked signals
32
Reported cases
32
Serious reports
11
Species represented
2
Most Reported Reactions
Reaction Cases Species Serious cases
1 Dog 1
1 Dog 1
1 Cat 1
1 Dog 1
1 Dog 1
1 Dog 1
1 Dog 1
1 Dog 1

Species coverage: Dog (20) Cat (12)

View detailed reaction table
Reaction Species Seriousness Frequency Reports
Cat Non-serious - 1
Cat Non-serious - 1
Dog Non-serious - 1
Cat Non-serious - 1
Cat Non-serious - 1
Dog Serious - 1
Dog Serious - 1
Dog Serious - 1
Dog Serious - 1
Cat Non-serious - 1
Dog Non-serious - 1
Dog Serious - 1
Dog Serious - 1
Dog Non-serious - 1
Dog Non-serious - 1
Dog Non-serious - 1
Dog Serious - 1
Dog Serious - 1
Cat Non-serious - 1
Cat Non-serious - 1
Dog Non-serious - 1
Cat Serious - 1
Dog Serious - 1
Dog Serious - 1
Cat Non-serious - 1
Cat Non-serious - 1
Dog Non-serious - 1
Cat Non-serious - 1
Dog Non-serious - 1
Dog Non-serious - 1
Cat Non-serious - 1
Dog Non-serious - 1
Source metadata:

Storage & Handling

No storage/handling guidance is linked yet.

Source metadata: No source yet.

Documents

Official label facts are separated from secondary summaries.

Official documents: 93 • Secondary summaries: 0

Official label facts
Secondary summaries

No source yet.

Source metadata:

Promotional Materials (Marketing)

This content is marketing material and not clinical guidance.

No marketing assets are linked yet.

No source yet.

Source metadata: No source yet.
Talk to a Vet / Find a Vet Near You
Technical appendix (vet reference)

Canonical medication sections are above. This legacy block remains available for deeper cross-reference without cluttering the primary workflow.

At a Glance

Quick facts and links to official labeling and safety signals.

Data freshness
  • Medication catalog: Source PetWisePlus | Refreshed Feb 12, 2026, 10:44 PM UTC
  • Animal Drugs @ FDA: Source FDA | Refreshed Feb 16, 2026, 11:00 AM UTC
    Applications/products are imported from FDA export data.
  • Animal Drugs @ FDA previews: Source FDA | Refreshed Feb 9, 2026, 3:05 AM UTC
    Label highlights/doc links are fetched from FDA preview endpoints.
  • Animal Drug Product Listing Directory (NDC): Source FDA | Refreshed Feb 16, 2026, 11:00 AM UTC
    Package/product NDCs from FDA’s electronic listing directory (XLS).
  • openFDA reaction terms: Source FDA openFDA | Refreshed Feb 16, 2026, 11:05 AM UTC
  • openFDA case summaries: Source FDA openFDA | Refreshed Feb 9, 2026, 3:22 AM UTC
Official (FDA)
Identity: Generic ingredient • FDA branded products available
Official FDA brands: Anaprime® Ophthalmic Solution Anaprime® Opthakote Ophthalmic Animax® Cream Animax® Ointment Bac-Neo-Poly Ophthalmic Ointment Vetropolycin Ophthalmic Ointment Biosol® Liquid Biosol® Sterile Solution Biosol® Sterile Solution 50 mg Cortisporin Veterinary Ophthalmic Ointment DERMA-VET® Ointment Derm-Otic Ointment Derma 4 Ointment Derma-Vet Cream Forte Topical® Ointment Hydeltrone Ointment Jenomycin Tablets Liquisone F with Cerumene Mycitracin® Sterile Ophthalmic Ointment Neo 200 Oral Solution Neo Predef® Sterile Ointment Neo-Aristovet Ointment Neo-Cortef® Sterile Ointment Neo-Cortef® with Tetracaine Neo-Darbazine Spansule Capsule No.3 Neo-Darbazine Spansule Capsule No.1 Neo-Delta Cortef® Sterile Solution Neo-Delta-Cortef® with Tetracaine Ointment Neo-Oxy 50/50® Neo-Oxy 100/100 MR® Neo-Predef® with Tetracaine Powder Neo-Sol® 50 Neo-Terramycin® 100/100 Neo-Terramycin® 50/50D Neo-Terramycin® 50/50 Neo-Terramycin® 100/100D Neo-synalar Cream NeoMed® Soluble Powder Neomix Ag® 325 Neomix® 325 Neomix® 325 Soluble Powder Neomix® AG 325 Soluble Powder Neomycane Ophthalmic Ointment Neomycin Liquid Neomycin Oral Solution Neomycin Sulfate Neomycin Sulfate 325 Neomycin and Polymyxin B Sulfates, and Bacitracin Zinc Ophthalmic Ointment Neosol Soluble Powder Neosol-Oral Neosporin Ophthalmic Ointment Optiprime® Opthakote Ophthalmic Solution Optisone Panolog® Cream Panolog® Ointment Thiabendazole, Dexamethasone, Neomycin Sulfate Solution Tresaderm Dermatologic Solution Tritop® Topical Ointment Neo-Predef® with Tetracaine Top. Ointment Tylan® Plus Neomycin Eye Powder Vetropolycin HC Ophthalmic Ointment Bacitracin-Neomycin-Polymyxin with Hydrocortisone Acetate Ophthalmic Ointment
Case-reported brands (openFDA): MSK
Catalog species: Both • FDA-labeled species: Baby Pigs, Beef, Beef And Non-Lactating Dairy, Breeding, Calves, Calves Up To 250 Pounds, Cat, Cattle, Dairy, Dog, Excluding lactating dairy, Excluding turkeys producing eggs for human consumption, Excluding veal calves or female dairy cattle 20 months of age or older, Goat, Goats, Growing, Horse, Kids, Lambs, No Use Class Stated Or Implied, No use class stated or implied, Not laying eggs for human consumption, Sheep
Rx/OTC: OTC, RX, VFD
Form/route: Cream, Liquid, Liquid (Solution), Liquid (Suspension), Ointment, Powder, Powder for oral solution, Soluble Powder, Solution, Sustained Release Capsule, Tablet, Type A Medicated Article • Intramuscular, Intravenous, Ophthalmic, Oral, Topical
Applications: NADA 138-939 • NADA 140-976 • NADA 11315 • NADA 140-810 • NADA 94975 • ANADA 200-046 • ANADA 200-245 • ANADA 200-289 • ANADA 200-553 • NADA 11437 • NADA 15433 • ANADA 200-050 • ANADA 200-330 • ANADA 200-118 • ANADA 200-153 • ANADA 200-235 • ANADA 200-113 • NADA 140-847 • NADA 140-879 • ANADA 200-379 • ANADA 200-378 • ANADA 200-130 • NADA 38801 • NADA 49725 • NADA 65016 • NADA 11953 • NADA 65476 • NADA 140-889 • NADA 141-003 • NADA 65119 • NADA 13181 • NADA 32322 • NADA 65114 • NADA 30045 • NADA 93514 • NADA 10524 • NADA 31914 • NADA 91534 • NADA 11703 • NADA 44655 • NADA 34872 • NADA 65485 • NADA 15151 • NADA 49726 • NADA 45288 • NADA 96676 • NADA 12258 • ANADA 200-565 • NADA 42633 • NADA 30025 • NADA 31962 • NADA 65015
NDC: Packages 43457-538-25 65876-0001-1 86191-032-01 • Products 43457 65876 86191
Documents: 30 (FOI: 26) • SPL: 63 • Label highlights • Official documents
Safety (openFDA)
Top reactions: Dog 8 • Cat 56 • View
Case summaries: 10 (showing 8) • View
openFDA reports are unverified and do not prove causation.
Explore
Linked using: Fda_Label (0.95), Fda_Label (0.95), Fda_Label (0.95)
Diagnosis Codes
ICD10_CM: A27.9 ICD10_CM: H60.90 ICD10_CM: L20.9
Leptospirosis, unspecified

Counseling and Monitoring Highlights

Global Pet owner/Vet mode is controlled in the header. This section avoids duplicate in-page persona tabs.

Owner-facing counseling points
  • Tetracaine and neomycin have the potential to sensitize. Care should be taken to observe animals being treated for evidence of hypersensitivity or allergy to the product. If such signs are noted, therapy with the product should be stopped. Incomplete response or exacerbation of corticosteroid responsive lesions may be due to the presence of non susceptible organisms or to prolonged use of antibiotic-containing preparations resulting in overgrowth of non susceptible organisms, particularly Monilia. Federal law restricts this drug to use by or on the order of a licensed veterinarian. Add to drinking water. Not for use in liquid supplements. Prepare a fresh solution daily. If symptoms persist after using this preparation for 2 or 3 days, consult a veterinarian. Treatment should continue 24-48 hours beyond remission of disease symptoms, but not to exceed a total of 14 days. Discontinue treatment 1 day prior to slaughter in cattle. A withdrawal period has not been established for use in preruminating calves. Do not use in calves to be processed for veal. Use of more than one product containing neomycin or failure to follow withdrawal times may result in illegal drug residues. Add to drinking water. Not for use in liquid supplements. Prepare a fresh solution daily. If symptoms persist after using this preparation for 2 or 3 days, consult a veterinarian. Treatment should continue 24-48 hours beyond remission of disease symptoms, but not to exceed a total of 14 days. Discontinue treatment 2 days prior to slaughter in sheep. Use of more than one product containing neomycin or failure to follow withdrawal times may result in illegal drug residues. (Contraindication, High)
Top reaction signals
Abnormal cytology (1) Abnormal radiograph finding (1) Anaemia NOS (1) Anorexia (1) Ataxia (1) Bumping into walls (1) Cataract (1) Circling - neurological disorder (see also Behavioural disorders) (1) Corneal disorder NOS (1) Decreased appetite (1) Decreased blood urea nitrogen (BUN) or creatinine (1) Dental plaque (1) Diarrhoea (1) Ear discharge (1) Ear pain (1) Head shake - ear disorder (1)

Identifiers & Packages

Normalized identifiers (NDC/NADA/ANADA) and package metadata from regulator listings.

Identifiers
ANADA: 200046 ANADA: 200050 ANADA: 200113 ANADA: 200118 ANADA: 200130 ANADA: 200153 ANADA: 200235 ANADA: 200245 ANADA: 200289 ANADA: 200330 ANADA: 200378 ANADA: 200379 ANADA: 200553 ANADA: 200565 NADA: 10524 NADA: 11315 NADA: 11437 NADA: 11703 NADA: 11953 NADA: 12258 NADA: 13181 NADA: 138939 NADA: 140810 NADA: 140847
Package NDC Product NDC Form / Route Status
0010-5587-01 0010 -
0010-5587-02 0010 -
0010-5587-03 0010 -
0010-5587-04 0010 -
13985-578-01 13985 -
13985-578-16 13985 -
17033-122-15 17033 -
17033-122-30 17033 -
17033-122-75 17033 -
17033-417-50 17033 -
23243-6755-1 23243 -
23243-6755-2 23243 -
23243-6755-3 23243 -
43457-538-25 43457 -
51429-010-03 51429 -
51429-055-03 51429 -
54771-1584-1 54771 -
55999-069-13 55999 -
55999-069-15 55999 -
55999-069-18 55999 -

Enriched Documents

Documents are tiered by source trust: Official, Clinical, Manufacturer, Marketing.

  • ucm115965.pdf • FOI summary • Official • July 30, 2025
    FDA FOI summary for application 140976
  • UCM523941.pdf • FOI summary • Official • July 2, 2025
    FDA FOI summary for application 11315
  • N011315_Supp_4_3_1996.pdf • FOI summary • Official • July 2, 2025
    FDA FOI summary for application 11315
  • ucm049525.pdf • FOI summary • Official • July 2, 2025
    FDA FOI summary for application 11315
  • N140810_Org_5_31_1988.pdf • FOI summary • Official • Jan. 21, 2025
    FDA FOI summary for application 140810
  • A200046_Orig_05_15_1992.pdf • FOI summary • Official • Nov. 12, 2024
    FDA FOI summary for application 200046
  • A200046_Supp_04_03_1996.pdf • FOI summary • Official • Nov. 12, 2024
    FDA FOI summary for application 200046
  • ucm061717.pdf • FOI summary • Official • Dec. 26, 2023
    FDA FOI summary for application 200289
  • ucm061671.pdf • FOI summary • Official • Dec. 26, 2023
    FDA FOI summary for application 200245
  • UCM457307.pdf • FOI summary • Official • Oct. 25, 2023
    FDA FOI summary for application 200553
  • A200050_Orig_02_15_1995.pdf • FOI summary • Official • Oct. 2, 2018
    FDA FOI summary for application 200050
  • A200050_Supp_04_03_1996.pdf • FOI summary • Official • Oct. 2, 2018
    FDA FOI summary for application 200050
  • ucm061573.pdf • FOI summary • Official • Oct. 2, 2018
    FDA FOI summary for application 200050
  • ucm061795.pdf • FOI summary • Official • Dec. 27, 2017
    FDA FOI summary for application 200330
  • A200118_Orig_11_29_1994..pdf • FOI summary • Official • Dec. 13, 2017
    FDA FOI summary for application 200118
  • A200118_Supp_7_14_1998.pdf • FOI summary • Official • Dec. 13, 2017
    FDA FOI summary for application 200118
  • A200153_Orig_05_08_1996.pdf • FOI summary • Official • July 28, 2017
    FDA FOI summary for application 200153
  • A200235_Orig_3_9_1998.pdf • FOI summary • Official • July 19, 2017
    FDA FOI summary for application 200235
  • A200113_Org_6_28_1993.pdf • FOI summary • Official • May 19, 2017
    FDA FOI summary for application 200113
  • A200113_Supp_02_07_1997.pdf • FOI summary • Official • May 19, 2017
    FDA FOI summary for application 200113
  • N140879_Org_8_2_1989.pdf • FOI summary • Official • May 17, 2017
    FDA FOI summary for application 140879
  • N140847_Org_9_30_1988.pdf • FOI summary • Official • May 17, 2017
    FDA FOI summary for application 140847
  • ucm061334.pdf • FOI summary • Official • Jan. 3, 2017
    FDA FOI summary for application 200379
  • ucm061332.pdf • FOI summary • Official • Jan. 3, 2017
    FDA FOI summary for application 200378
  • ucm061598.pdf • FOI summary • Official • Jan. 3, 2017
    FDA FOI summary for application 200130
  • UCM457231.pdf • FOI summary • Official • June 1, 2016
    FDA FOI summary for application 200565

Data Sources & Revision History

Every non-trivial field is expected to include provenance and update timestamps.

Official 29 Clinical 0 Manufacturer 0 Marketing 0
Current Field Facts
  • contraindications: Tetracaine and neomycin have the potential to sensitize. Care should be taken to observe animals being treated for evidence of hypersensitivity or allergy to t… (Official, 2026-02-12)
  • side_effects: Top reported reactions (openFDA): Lethargy (see also Central nervous system depression in 'Neurological'), Loss of hearing, Deafness, Lack of efficacy - NOS, V… (Official, 2026-02-12)
  • usage: It is indicated for treating acute otitis externa and, to a lesser degree, chronic otitis externa in dogs. In treatment of ear canker and other inflammatory co… (Official, 2026-02-12)
Recent Revisions
  • side_effects updated 2026-02-12 22:44 by etl_backfill • Backfilled from existing medication fields
  • contraindications updated 2026-02-12 22:44 by etl_backfill • Backfilled from existing medication fields
  • usage updated 2026-02-12 22:44 by etl_backfill • Backfilled from existing medication fields

FDA Products & Applications (Animal Drugs @ FDA)

Official sponsor/proprietary-name/application-status records linked by active ingredient.

Product Sponsor Application Status Published
Neo-Oxy 50/50® Neo-Oxy 100/100 MR®
VFD
Neomycin Sulfate Oxytetracycline Hydrochloride
Type A Medicated Article • Oral
Label highlights
Official documents
Pharmgate Inc. NADA 138-939 Approved Oct 15, 2025
Neomix Ag® 325 Neomix® 325
VFD
Neomycin Sulfate
Type A Medicated Article • Oral
Label highlights
Official documents
Phibro Animal Health Corp. NADA 140-976 Approved Jul 30, 2025
Neomix® 325 Soluble Powder Neomix® AG 325 Soluble Powder
RX
Neomycin Sulfate
Powder for oral solution • Oral
Label highlights
Official documents
Phibro Animal Health Corp. NADA 11315 Approved Jul 2, 2025
DERMA-VET® Ointment
RX
Neomycin Sulfate Nystatin Thiostrepton Triamcinolone Acetonide
Ointment • Topical
Label highlights
Official documents
Med-Pharmex, Inc. NADA 140-810 W Jan 21, 2025
Neo-Terramycin® 100/100 Neo-Terramycin® 50/50D Neo-Terramycin® 50/50 Neo-Terramycin® 100/100D
VFD
Neomycin Sulfate Oxytetracycline
Oral
Label highlights
Official documents
Phibro Animal Health Corp. NADA 94975 Approved Jan 16, 2025
Neomycin Sulfate
RX
Neomycin Sulfate
Soluble Powder • Oral
Label highlights
Official documents
Phibro Animal Health Corp. ANADA 200-046 Approved Nov 12, 2024
Derma-Vet Cream
RX
Neomycin Sulfate Nystatin Thiostrepton Triamcinolone Acetonide
Cream • Topical
Label highlights
Official documents
Med-Pharmex, Inc. ANADA 200-245 W Dec 26, 2023
Neosol-Oral
RX
Neomycin Sulfate
Liquid (Solution) • Oral
Label highlights
Official documents
Med-Pharmex, Inc. ANADA 200-289 W Dec 26, 2023
Neomycin and Polymyxin B Sulfates, and Bacitracin Zinc Ophthalmic Ointment
RX
Bacitracin Zinc Neomycin Sulfate Polymyxin B Sulfate
Ointment • Ophthalmic
Label highlights
Official documents
Domes Pharma S.A. ANADA 200-553 Approved Oct 25, 2023
Hydeltrone Ointment
RX
Neomycin Sulfate Prednisolone Sodium Phosphate
Ointment • Ophthalmic, Topical
Label highlights
Official documents
Boehringer lngelheim Animal Health USA Inc. NADA 11437 W May 3, 2023
Neo-Predef® with Tetracaine Powder
RX
Isoflupredone Acetate Neomycin Sulfate Tetracaine Hydrochloride
Powder • Topical
Label highlights
Official documents
Zoetis Inc. NADA 15433 Approved Dec 17, 2019
NeoMed® Soluble Powder
RX
Neomycin Sulfate
Liquid (Solution) • Oral
Label highlights
Official documents
Bimeda Animal Health Limited ANADA 200-050 Approved Oct 2, 2018
Animax® Cream
RX
Neomycin Sulfate Nystatin Thiostrepton Triamcinolone Acetonide
Cream • Topical
Label highlights
Official documents
Fougera Pharmaceuticals, Inc. ANADA 200-330 Approved Dec 27, 2017
Neomycin Oral Solution
RX
Neomycin Sulfate
Liquid (Solution) • Oral
Label highlights
Official documents
Huvepharma EOOD ANADA 200-118 Approved Dec 13, 2017
Neo 200 Oral Solution
RX
Neomycin Sulfate
Liquid (Solution) • Oral
Label highlights
Official documents
Huvepharma EOOD ANADA 200-153 Approved Jul 28, 2017
Neosol Soluble Powder
RX
Neomycin Sulfate
Liquid (Solution) • Oral
Label highlights
Official documents
Med-Pharmex, Inc. ANADA 200-235 Approved Jul 19, 2017
Biosol® Liquid
RX
Neomycin Sulfate
Liquid (Solution) • Oral
Label highlights
Official documents
Zoetis Inc. ANADA 200-113 Approved May 19, 2017
Animax® Ointment
RX
Neomycin Sulfate Nystatin Thiostrepton Triamcinolone Acetonide
Ointment • Topical
Label highlights
Official documents
Fougera Pharmaceuticals, Inc. NADA 140-847 Approved May 17, 2017
Derma 4 Ointment
RX
Neomycin Sulfate Nystatin Thiostrepton Triamcinolone Acetonide
Ointment • Topical
Label highlights
Official documents
Zoetis Inc. NADA 140-879 Approved May 17, 2017
Neomycin Liquid
RX
Neomycin Sulfate
Liquid (Solution) • Oral
Label highlights
Official documents
Sparhawk Laboratories, Inc. ANADA 200-379 Approved Jan 3, 2017
Neomycin Sulfate 325
RX
Neomycin Sulfate
Soluble Powder • Oral
Label highlights
Official documents
Sparhawk Laboratories, Inc. ANADA 200-378 Approved Jan 3, 2017
Neo-Sol® 50
RX
Neomycin Sulfate
Soluble Powder • Oral
Label highlights
Official documents
Huvepharma EOOD ANADA 200-130 Approved Jan 3, 2017
Anaprime® Ophthalmic Solution
RX
Flumethasone Neomycin Sulfate Polymyxin B Sulfate
Liquid • Ophthalmic
Label highlights
Official documents
Zoetis Inc. NADA 38801 Approved Jun 1, 2016
Anaprime® Opthakote Ophthalmic
RX
Flumethasone Neomycin Sulfate Polymyxin B Sulfate
Liquid • Ophthalmic
Label highlights
Official documents
Zoetis Inc. NADA 49725 Approved Jun 1, 2016
Bac-Neo-Poly Ophthalmic Ointment Vetropolycin Ophthalmic Ointment
RX
Bacitracin Zinc Neomycin Sulfate Polymyxin B Sulfate
Ointment • Ophthalmic
Label highlights
Official documents
Dechra, Ltd. NADA 65016 Approved Jun 1, 2016
Biosol® Sterile Solution Biosol® Sterile Solution 50 mg
RX
Neomycin Sulfate
Liquid (Solution) • Intramuscular, Intravenous
Label highlights
Official documents
Zoetis Inc. NADA 11953 Approved Jun 1, 2016
Cortisporin Veterinary Ophthalmic Ointment
RX
Bacitracin Zinc Hydrocortisone Neomycin Sulfate Polymyxin B Sulfate
Ointment • Ophthalmic
Label highlights
Official documents
Intervet, Inc. NADA 65476 Approved Jun 1, 2016
Derm-Otic Ointment
RX
Neomycin Sulfate Nystatin Thiostrepton Triamcinolone Acetonide
Ointment • Topical
Label highlights
Official documents
Biocraft Laboratories, Inc. NADA 140-889 W Jun 1, 2016
Derm-Otic Ointment
RX
Neomycin Sulfate Nystatin Thiostrepton Triamcinolone Acetonide
Ointment • Topical
Label highlights
Official documents
Zoetis Inc. NADA 141-003 Approved Jun 1, 2016
Forte Topical® Ointment
RX
Hydrocortisone Acetate Neomycin Sulfate Penicillin G Procaine Polymyxin B Sulfate
Ointment • Topical
Label highlights
Official documents
Zoetis Inc. NADA 65119 Approved Jun 1, 2016
Jenomycin Tablets
RX
Aminopropazine Fumarate Neomycin Sulfate
Tablet • Oral
Label highlights
Official documents
Intervet, Inc. NADA 13181 Approved Jun 1, 2016
Liquisone F with Cerumene
RX
Hexamethyltetracosane Neomycin Sulfate Prednisolone Tetracaine
Liquid (Suspension) • Topical
Label highlights
Official documents
Evsco Pharmaceuticals, An Affiliate of IGI, Inc. NADA 32322 W Jun 1, 2016
Mycitracin® Sterile Ophthalmic Ointment
OTC
Bacitracin Zinc Neomycin Sulfate Polymyxin B Sulfate
Ointment • Ophthalmic
Label highlights
Official documents
Zoetis Inc. NADA 65114 Approved Jun 1, 2016
Neo-Aristovet Ointment
RX
Neomycin Sulfate Triamcinolone Acetonide
Official documents
Bayer HealthCare LLC, Animal Health Division NADA 30045 W Jun 1, 2016
Neo-Cortef® Sterile Ointment
RX
Hydrocortisone Acetate Neomycin Sulfate
Ointment • Ophthalmic
Label highlights
Official documents
Zoetis Inc. NADA 93514 Approved Jun 1, 2016
Neo-Cortef® with Tetracaine
RX
Hydrocortisone Acetate Neomycin Sulfate Tetracaine Hydrochloride
Ointment • Topical
Label highlights
Official documents
Zoetis Inc. NADA 10524 Approved Jun 1, 2016
Neo-Darbazine Spansule Capsule No.3 Neo-Darbazine Spansule Capsule No.1
RX
Isopropamide Iodide Neomycin Sulfate Prochlorperazine Dimaleate
Sustained Release Capsule • Oral
Label highlights
Official documents
Zoetis Inc. NADA 31914 Approved Jun 1, 2016
Neo-Delta Cortef® Sterile Solution
RX
Neomycin Sulfate Prednisolone Acetate
Liquid (Suspension) • Ophthalmic
Label highlights
Official documents
Zoetis Inc. NADA 91534 Approved Jun 1, 2016
Neo-Delta-Cortef® with Tetracaine Ointment
RX
Neomycin Sulfate Prednisolone Acetate Tetracaine Hydrochloride
Liquid (Suspension) • Ophthalmic
Official documents
Zoetis Inc. NADA 11703 Approved Jun 1, 2016
Neomycane Ophthalmic Ointment
OTC
Neomycin Sulfate
Ointment • Ophthalmic
Label highlights
Official documents
Evsco Pharmaceuticals, An Affiliate of IGI, Inc. NADA 44655 W Jun 1, 2016
Neo Predef® Sterile Ointment
RX
Isoflupredone Acetate Neomycin Sulfate
Ointment • Ophthalmic, Topical
Official documents
Zoetis Inc. NADA 34872 Approved Jun 1, 2016
Neosporin Ophthalmic Ointment
RX
Bacitracin Zinc Neomycin Sulfate Polymyxin B Sulfate
Ointment • Ophthalmic
Label highlights
Official documents
Intervet, Inc. NADA 65485 Approved Jun 1, 2016
Neo-synalar Cream
RX
Fluocinolone Acetonide Neomycin Sulfate
Cream • Topical
Label highlights
Official documents
Bausch Health US, LLC NADA 15151 Approved Jun 1, 2016
Optiprime® Opthakote Ophthalmic Solution
RX
Neomycin Sulfate Polymyxin B Sulfate
Liquid (Solution) • Ophthalmic
Label highlights
Official documents
Zoetis Inc. NADA 49726 Approved Jun 1, 2016
Optisone
RX
Neomycin Sulfate Prednisolone Acetate
Ointment • Ophthalmic
Official documents
Evsco Pharmaceuticals, An Affiliate of IGI, Inc. NADA 45288 W Jun 1, 2016
Panolog® Cream
RX
Neomycin Sulfate Nystatin Thiostrepton Triamcinolone Acetonide
Cream • Topical
Label highlights
Official documents
Zoetis Inc. NADA 96676 Approved Jun 1, 2016
Panolog® Ointment
RX
Neomycin Sulfate Nystatin Thiostrepton Triamcinolone Acetonide
Ointment • Topical
Label highlights
Official documents
Zoetis Inc. NADA 12258 Approved Jun 1, 2016
Thiabendazole, Dexamethasone, Neomycin Sulfate Solution
RX
Dexamethasone Neomycin Sulfate Thiabendazole
Solution • Topical
Label highlights
Official documents
Dechra Veterinary Products LLC ANADA 200-565 Approved Jun 1, 2016
Tresaderm Dermatologic Solution
RX
Dexamethasone Neomycin Sulfate Thiabendazole
Liquid (Solution) • Topical
Label highlights
Official documents
Boehringer lngelheim Animal Health USA, Inc. NADA 42633 Approved Jun 1, 2016
Tritop® Topical Ointment Neo-Predef® with Tetracaine Top. Ointment
RX
Isoflupredone Acetate Neomycin Sulfate Tetracaine Hydrochloride
Ointment • Topical
Label highlights
Official documents
Zoetis Inc. NADA 30025 Approved Jun 1, 2016
Tylan® Plus Neomycin Eye Powder
OTC
Neomycin Sulfate Tylosin
Official documents
Elanco Animal Health, A Division of Eli Lilly & Co. NADA 31962 W Jun 1, 2016
Vetropolycin HC Ophthalmic Ointment Bacitracin-Neomycin-Polymyxin with Hydrocortisone Acetate Ophthalmic Ointment
RX
Bacitracin Zinc Hydrocortisone Acetate Neomycin Sulfate Polymyxin B Sulfate
Ointment • Ophthalmic
Label highlights
Official documents
Dechra, Ltd. NADA 65015 Approved Jun 1, 2016

Data source: FDA Animal Drugs @ FDA (public search export).

What It's For (FDA Label Highlights)

Extracted from FDA Animal Drugs @ FDA product labeling. Always confirm details with your veterinarian.

Species: Breeding • No use class stated or implied • Calves Up To 250 Pounds • Growing, Over 400 Pounds • Beef And Non-Lactating Dairy • Calves, 250 to 400 pounds, excluding veal • Growing • No use class stated or implied • No use class stated or implied • Sheep, No Use Class Stated Or Implied
Composition / specifications
Type A medicated articles containing oxytetracycline equivalent to 50 grams per pound (g/lb) oxytetracycline hydrochloride and 50 g/lb neomycin sulfate or oxytetracycline equivalent to 100 g/lb oxytetracycline hydrochloride and 100 g/lb neomycin sulfate.
Chickens
Indication

For control of chronic respiratory disease (CRD) and air sac infection caused by Mycoplasma gallisepticum and Escherichia coli susceptible to oxytetracycline.

Dosage

400 g/ton

Limitations

Feed continuously for 7-14 days; do not feed to chickens producing eggs for human consumption; in low calcium feed, withdraw 3 days before slaughter.

Indication

For reduction of mortality due to air sacculitis (air sac infection) caused by Escherichia coli susceptible to oxytetracycline.

Dosage

500 g/ton

Limitations

Feed continuously for 5 days; do not feed to chickens producing eggs for human consumption; withdraw 24 hours before slaughter; in low calcium feed, withdraw 3 days before slaughter.

Indication

For control of infectious synovitis caused by Mycoplasma synoviae, control of fowl cholera caused by Pasteurella multocida susceptible to oxytetracycline.

Dosage

100 to 200 g/ton

Limitations

Feed continuously for 7-14 days; do not feed to chickens producing eggs for human consumption; in low calcium feed, withdraw 3 days before slaughter.

Turkeys
Indication

For control of complicating bacterial organisms associated with bluecomb (transmissible enteritis, coronaviral enteritis) susceptible to oxytetracycline.

Dosage

25 mg/lb body weight/day

Limitations

Feed continuously for 7 to 14 days; withdraw 5 days before slaughter; do not feed to turkeys producing eggs for human consumption.

Indication

For control of hexamitiasis caused by Hexamita meleagridis susceptible to oxytetracycline.

Dosage

100 g/ton

Limitations

Feed continuously for 7 to 14 days; do not feed to turkeys producing eggs for human consumption.

Indication

For control of infectious synovitis caused by Mycoplasma synoviae susceptible to oxytetracycline.

Dosage

200 g/ton

Limitations

Feed continuously for 7 to 14 days; withdraw 5 days before slaughter; do not feed to turkeys producing eggs for human consumption.

Swine
Indication

For treatment of bacterial enteritis caused by Escherichia coli and Salmonella choleraesuis and treatment of bacterial pneumonia caused by Pasteurella multocida susceptible to oxytetracycline; treatment and control of colibacillosis (bacterial enteritis) caused by Escherichia coli susceptible to neomycin.

Dosage

10 mg/lb/body weight/day

Limitations

Feed continuously for 7 to 14 days; withdraw 5 days before slaughter.

Swine (breeding)
Indication

For control and treatment of leptospirosis (reducing the incidence of abortion and shedding of leptospirae) caused by Leptospira Pomona susceptible to oxytetracycline.

Dosage

10 mg/lb/body weight/day

Limitations

Feed continuously for not more than 14 days; withdraw 5 days before slaughter.

Sheep
Indication

For treatment of bacterial enteritis caused by Escherichia coli and bacterial pneumonia caused by Pasteurella multocida susceptible to oxytetracycline; treatment and control of colibacillosis (bacterial enteritis) caused by Escherichia coli susceptible to neomycin.

Dosage

10 mg/lb body weight/day

Limitations

Feed continuously for 7-14 days. Treatment should continue 24 to 48 hours beyond remission of disease symptoms. Withdraw 5 days before slaughter.

Cattle (calves up to 250 lbs)
Indication

For treatment of bacterial enteritis caused by Escherichia coli susceptible to oxytetracycline; treatment and control of colibacillosis (bacterial enteritis) caused by Escherichia coli susceptible to neomycin.

Dosage

10 mg/lb body weight/day

Limitations

Feed continuously for 7 to 14 days; in milk replacers or starter feed. Treatment should continue 24 to 48 hours beyond remission of disease symptoms. A withdrawal period has not been established for use in pre-ruminating calves. Do not use in calves to be processed for veal.

Growing cattle (over 400 lbs)
Indication

For the reduction of the incidence of liver abscesses.

Dosage

75 mg/head/day

Limitations

Feed continuously.

Cattle
Indication

For the prevention and treatment of the early stages of shipping fever complex.

Dosage

0.5 to 2.0 g/head/day

Limitations

Feed 3-5 days before and after arrival in feedlots. A withdrawal period has not been established for use in pre-ruminating calves. Do not use in calves to be processed for veal. A milk discard time has not been established for use in lactating dairy cattle. Do not use in female dairy cattle 20 months of age or older.

Cattle (calves and beef and nonlactating dairy cattle)
Indication

For treatment of bacterial enteritis caused by Escherichia coli and bacterial pneumonia (shipping fever complex) caused by Pasteurella multocida susceptible to oxytetracycline; treatment and control of colibacillosis (bacterial enteritis) caused by Escherichia coli susceptible to neomycin.

Dosage

10 mg/lb body weight/day

Limitations

Feed continuously for 7-14 days in feed or milk replacers. Treatment should continue 24 to 48 hours beyond remission of disease symptoms. A withdrawal period has not been established for use in pre-ruminating calves. Do not use in calves to be processed for veal. A milk discard time has not been established for use in lactating dairy cattle. Do not use in female dairy cattle 20 months of age or older. Withdraw 5 days before slaughter.

FDA page: Open in Animal Drugs @ FDA

Species: Goats, excluding lactating goats, excluding dairy females 12 months of age or older • Kids • Baby Pigs • No use class stated or implied • Excluding lactating dairy, excluding dairy females 20 months of age or older • Calves, excluding veal calves • Sheep, No Use Class Stated Or Implied • Lambs
Composition / specifications
325 g neomycin sulfate per lb
Cattle, swine, sheep, and goats, and their offspring
Indication

For the treatment and control of colibacillosis (bacterial enteritis) caused by Escherichia coli susceptible to neomycin sulfate in cattle, swine, sheep, goats and their offspring.

Dosage

Type C milk replacer 400 to 2,000 grams per ton.

Type C feed 250 to 2,500 grams per ton.

Limitations

FDA page: Open in Animal Drugs @ FDA

Species: Goat, No Use Class Stated Or Implied • No use class stated or implied • Excluding veal calves or female dairy cattle 20 months of age or older • Growing • Sheep, No Use Class Stated Or Implied
Composition / specifications
The drug contains 20.3 grams of neomycin sulfate per ounce which is equivalent to 14.2 grams of neomycin base.
Cattle (excluding veal calves or female dairy cattle 20 months of age or older)
Indication

For the treatment and control of colibacillosis (bacterial enteritis) caused by Escherichia coli susceptible to neomycin sulfate in cattle.

Dosage
10 milligrams of neomycin sulfate per pound of body weight per day (22 milligrams per kilogram) in divided doses for a maximum of 14 days.
Limitations

Add to drinking water. Not for use in liquid supplements. Prepare a fresh solution daily. If symptoms persist after using this preparation for 2 or 3 days, consult a veterinarian. Treatment should continue 24-48 hours beyond remission of disease symptoms, but not to exceed a total of 14 days. Discontinue treatment 1 day prior to slaughter in cattle. A withdrawal period has not been established for use in preruminating calves. Do not use in calves to be processed for veal. Use of more than one product containing neomycin or failure to follow withdrawal times may result in illegal drug residues.

Sheep
Indication

For the treatment and control of colibacillosis (bacterial enteritis) caused by Escherichia coli susceptible to neomycin sulfate in sheep.

Dosage
10 milligrams of neomycin sulfate per pound of body weight per day (22 milligrams per kilogram) in divided doses for a maximum of 14 days.
Limitations

Add to drinking water. Not for use in liquid supplements. Prepare a fresh solution daily. If symptoms persist after using this preparation for 2 or 3 days, consult a veterinarian. Treatment should continue 24-48 hours beyond remission of disease symptoms, but not to exceed a total of 14 days. Discontinue treatment 2 days prior to slaughter in sheep. Use of more than one product containing neomycin or failure to follow withdrawal times may result in illegal drug residues.

Swine
Indication

For the treatment and control of colibacillosis (bacterial enteritis) caused by Escherichia coli susceptible to neomycin sulfate in swine.

Dosage
10 milligrams of neomycin sulfate per pound of body weight per day (22 milligrams per kilogram) in divided doses for a maximum of 14 days.
Limitations

Add to drinking water. Not for use in liquid supplements. Prepare a fresh solution daily. If symptoms persist after using this preparation for 2 or 3 days, consult a veterinarian. Treatment should continue 24-48 hours beyond remission of disease symptoms, but not to exceed a total of 14 days. Discontinue treatment 3 days prior to slaughter in swine. Use of more than one product containing neomycin or failure to follow withdrawal times may result in illegal drug residues.

Goats
Indication

For the treatment and control of colibacillosis (bacterial enteritis) caused by Escherichia coli susceptible to neomycin sulfate in goats.

Dosage
10 milligrams of neomycin sulfate per pound of body weight per day (22 milligrams per kilogram) in divided doses for a maximum of 14 days.
Limitations

Add to drinking water. Not for use in liquid supplements. Prepare a fresh solution daily. If symptoms persist after using this preparation for 2 or 3 days, consult a veterinarian. Treatment should continue 24-48 hours beyond remission of disease symptoms, but not to exceed a total of 14 days. Discontinue treatment 3 days prior to slaughter in goats. Use of more than one product containing neomycin or failure to follow withdrawal times may result in illegal drug residues.

Turkeys (growing)
Indication

For the control of mortality associated with E. coli organisms susceptible to neomycin sulfate in growing turkeys.

Dosage
10 milligrams of neomycin sulfate per pound of body weight per day (22 milligrams per kilogram) for 5 days.
Limitations

Add to drinking water. Not for use in liquid supplements. Prepare a fresh solution daily. If symptoms persist after using this preparation for 2 or 3 days, consult a veterinarian. Treatment should continue 24 to 48 hours beyond remission of disease symptoms, but not to exceed a total of 5 consecutive days. Use of more than one product containing neomycin or failure to follow withdrawal times may result in illegal drug residues.

FDA page: Open in Animal Drugs @ FDA

Species: Dog, No Use Class Stated Or Implied • Cat, No Use Class Stated Or Implied
Composition / specifications
Each milliliter of petrolatum base or each gram of vanishing cream base ointment contains: 100,000 units of nystatin; neomycin sulfate equivalent to 2.5 milligrams of neomycin base; 2,500 units of thiostrepton; and 1.0 milligram of triamcinolone acetonide.
Cats
Indication
For cystic areas. Use petrolatum base ointment for the treatment interdigital cysts.
Dosage
Drain gland or cyst and fill with petrolatum base ointment. For mild inflammations, use once daily to once a week. For severe conditions, apply initially two to three times daily, decreasing frequency as improvement occurs.
Limitations
Not intended for treatment of deep abscesses or deep-seated infections. Not for ophthalmic use. Federal law restricts this drug to use by or on the order of a licensed veterinarian.
Indication
For topical dermatological use. Use either ointment for anti-inflammatory, antipruritic, antifungal, and antibacterial treatment of superficial bacterial infections, and for dermatologic disorders characterized by inflammation and dry or exudative dermatitis, particularly associated with bacterial or candidal (Candida albicans) infections.
Dosage
Clean affected areas and remove any encrusted discharge or exudate, and apply sparingly either ointment in a thin film. For mild inflammations, use once daily to once a week. For severe conditions, apply initially two to three times daily, decreasing frequency as improvement occurs.
Limitations
Not intended for treatment of deep abscesses or deep-seated infections. Not for ophthalmic use. Federal law restricts this drug to use by or on the order of a licensed veterinarian.
Indication
For otic use. Use petrolatum base ointment for the treatment of acute and chronic otitis.
Dosage
Clean ear canal of impacted cerumen, remove any foreign bodies such as grass awns and ticks, and instill three to five drops of petrolatum base ointment. Preliminary use of a local anesthetic may be advisable. For mild inflammations, use once daily to once a week. For severe conditions, apply initially two to three times daily, decreasing frequency as improvement occurs.
Limitations
Not intended for treatment of deep abscesses or deep-seated infections. Not for ophthalmic use. Federal law restricts this drug to use by or on the order of a licensed veterinarian.
Dogs
Indication
For infected anal glands and cystic areas. Use petrolatum base ointment in for the treatment interdigital cysts and for anal gland infections.
Dosage
Drain gland or cyst and fill with petrolatum base ointment. For mild inflammations, use once daily to once a week. For severe conditions, apply initially two to three times daily, decreasing frequency as improvement occurs.
Limitations
Not intended for treatment of deep abscesses or deep-seated infections. Not for ophthalmic use. Federal law restricts this drug to use by or on the order of a licensed veterinarian.
Indication
For topical dermatological use. Use either ointment for anti-inflammatory, antipruritic, antifungal, and antibacterial treatment of superficial bacterial infections, and for dermatologic disorders characterized by inflammation and dry or exudative dermatitis, particularly associated with bacterial or candidal (Candida albicans) infections.
Dosage
Clean affected areas and remove any encrusted discharge or exudate, and apply sparingly either ointment in a thin film. For mild inflammations, use once daily to once a week. For severe conditions, apply initially two to three times daily, decreasing frequency as improvement occurs.
Limitations
Not intended for treatment of deep abscesses or deep-seated infections. Not for ophthalmic use. Federal law restricts this drug to use by or on the order of a licensed veterinarian.
Indication
For otic use. Use petrolatum base ointment for the treatment of acute and chronic otitis.
Dosage
Clean ear canal of impacted cerumen, remove any foreign bodies such as grass awns and ticks, and instill three to five drops of petrolatum base ointment. Preliminary use of a local anesthetic may be advisable. For mild inflammations, use once daily to once a week. For severe conditions, apply initially two to three times daily, decreasing frequency as improvement occurs.
Limitations
Not intended for treatment of deep abscesses or deep-seated infections. Not for ophthalmic use. Federal law restricts this drug to use by or on the order of a licensed veterinarian.

FDA page: Open in Animal Drugs @ FDA

Species: Breeding • No use class stated or implied • Beef • Calves • Dairy, non-lactating • Not laying eggs for human consumption • Excluding turkeys producing eggs for human consumption • Sheep, No Use Class Stated Or Implied
Composition / specifications
oxytetracycline equivalent to 50 g [or 100 g] oxytetracycline hydrochloride /lb and
50 g [or 100 g] neomycin sulfate /lb
Chickens
Indication
Control of infectious synovitis caused by Mycoplasma synoviae; control of fowl cholera caused by Pasteurella multocida susceptible to oxytetracycline
Dosage
100-200 g/ton
Limitations

Feed continuously for 7 to 14 days. Do not feed to chickens producing eggs for human consumption. In low calcium feed, withdraw 3 days before slaughter. Federal law restricts medicated feed containing this veterinary feed directive (VFD) drug to use by or on the order of a licensed veterinarian.

Indication

For reduction of mortality due to air sacculitis (air sac infection) caused by E. coli susceptible to oxytetracycline.

Dosage

500 g/ton

Limitations

Feed continuously for 5 days. Do not feed to chickens producing eggs for human consumption. Withdraw 24 hours before slaughter. In low calcium feed, withdraw 3 days before slaughter. Federal law restricts medicated feed containing this veterinary feed directive (VFD) drug to use by or on the order of a licensed veterinarian.

Indication

For control of chronic respiratory disease (CRD) and air sac infection caused by M. gallisepticum and Escherichia coli susceptible to oxytetracycline.

Dosage

400 g/ton

Limitations

Feed continuously for 7 to 14 days. Do not feed to chickens producing eggs for human consumption. In low calcium feed, withdraw 3 days before slaughter. Federal law restricts medicated feed containing this veterinary feed directive (VFD) drug to use by or on the order of a licensed veterinarian.

Turkeys
Indication
Control of complicating bacterial organisms associated with bluecomb (transmissible enteritis, coronaviral enteritis) susceptible to oxytetracycline
Dosage
25 mg/lb of body weight daily
Limitations

Feed continuously for 7 to 14 days. Withdraw 5 days before slaughter. Do not feed to turkeys producing eggs for human consumption. Federal law restricts medicated feed containing this veterinary feed directive (VFD) drug to use by or on the order of a licensed veterinarian.

Indication
Control of hexamitiasis caused by Hexamita meleagridis susceptible to oxytetracycline
Dosage
100 g/ton
Limitations

Feed continuously for 7 to 14 days. Do not feed to turkeys producing eggs for human consumption. Federal law restricts medicated feed containing this veterinary feed directive (VFD) drug to use by or on the order of a licensed veterinarian.

Indication
Control of infectious synovitis caused by Mycoplasma synoviae susceptible to oxytetracycline
Dosage
200 g/ton
Limitations

Feed continuously for 7 to 14 days. Withdraw 5 days before slaughter. Do not feed to turkeys producing eggs for human consumption. Federal law restricts medicated feed containing this veterinary feed directive (VFD) drug to use by or on the order of a licensed veterinarian.

Swine
Indication

Treatment of bacterial enteritis caused by E. coli and Salmonella choleraesuis susceptible to oxytetracycline and treatment of bacterial pneumonia caused by Pasteurella multocida susceptible to oxytetracycline; treatment and control of colibacillosis (bacterial enteritis) caused by E. coli susceptible to neomycin.

Dosage

10 mg/lb of body weight daily. 

Limitations

Feed continuously for 7-14 days. 5-day withdrawal before slaughter. Federal law restricts medicated feed containing this veterinary feed directive (VFD) drug to use by or on the order of a licensed veterinarian.

Breeding Swine
Indication

For breeding swine for control and treatment of Leptospirosis (reducing the incidence of abortion and shedding of leptospirae) caused by Leptospira pomona susceptible to oxytetracycline

Dosage
10 mg/lb of body weight daily
Limitations

Feed continuously for not more than 14 days. Withdraw 5 days before slaughter. Federal law restricts medicated feed containing this veterinary feed directive (VFD) drug to use by or on the order of a licensed veterinarian.

Sheep
Indication

Treatment of bacterial enteritis caused by E. coli and bacterial pneumonia caused by Pasteurella multocida susceptible to oxytetracycline; treatment and control of colibacillosis (bacterial enteritis) caused by E. coli susceptible to neomycin.

Dosage

10 mg/lb of body weight daily

Limitations

Feed continuously for 7-14 days. Treatment should continue 24 to 48 hours beyond remission of disease symptoms. Federal law restricts medicated feed containing this veterinary feed directive (VFD) drug to use by or on the order of a licensed veterinarian.

Calves (Up to 250 Lbs)
Indication
For treatment of bacterial enteritis caused by E. coli susceptible to oxytetracycline; treatment and control of colibacillosis (bacterial enteritis) caused by E. coli susceptible to neomycin
Dosage
10 mg/lb of body weight daily
Limitations

Feed continuously for 7 to 14 days. Treatment should continue 24 to 48 hours beyond remission of disease symptoms. A withdrawal period has not been established for use in preruminating calves. Do not use in calves to be processed for veal. A milk discard time has not been established for use in lactating dairy cattle. Do not use in female dairy cattle 20 months of age or older. Withdraw 5 days before slaughter. Federal law restricts medicated feed containing this veterinary feed directive (VFD) drug to use by or on the order of a licensed veterinarian.

Growing Cattle (Over 400 Lbs)
Indication

For reduction of liver condemnation due to liver abscesses.

Dosage
75 mg/head/day
Limitations

Feed continuously. Federal law restricts medicated feed containing this veterinary feed directive (VFD) drug to use by or on the order of a licensed veterinarian.

Calves, Beef Cattle, and Non-Lactating Dairy
Indication

Calves and beef and non-lactating dairy cattle: For treatment of bacterial enteritis caused by E. coli and bacterial pneumonia (shipping fever complex) caused by P. multocida susceptible to oxytetracycline; treatment and control of colibacillosis (bacterial enteritis) caused by E. coli susceptible to neomycin.

Dosage

10 mg/lb body weight (BW)

Limitations

Feed continuously for 7 to 14 days. Treatment should continue 24 to 48 hours beyond remission of disease symptoms. A withdrawal period has not been established for use in preruminating calves. Do not use in calves to be processed for veal. A milk discard time has not been established for use in lactating dairy cattle. Do not use in female dairy cattle 20 months of age or older. Withdraw 5 days before slaughter. Federal law restricts medicated feed containing this veterinary feed directive (VFD) drug to use by or on the order of a licensed veterinarian.

Cattle
Indication

For prevention and treatment of the early stages of shipping fever complex.

Dosage

0.5 to 2.0 g/head/day

Limitations

Feed 3 to 5 days before and after arrival in feedlots. A withdrawal period has not been established for use in preruminating calves. Do not use in calves to be processed for veal. A milk discard time has not been established for use in lactating dairy cattle. Do not use in female dairy cattle 20 months of age or older. Federal law restricts medicated feed containing this veterinary feed directive (VFD) drug to use by or on the order of a licensed veterinarian.

FDA page: Open in Animal Drugs @ FDA

Species: Goat, No Use Class Stated Or Implied • No use class stated or implied • Cattle, Excluding Veal Calves • Sheep, No Use Class Stated Or Implied
Composition / specifications
The drug contains 20.3 grams of neomycin sulfate per ounce which is equivalent to 14.2 grams of neomycin base.
Cattle (excluding veal calves)
Indication
For the treatment and control of colibacillosis (bacterial enteritis) caused by Escherichia coli susceptible to neomycin sulfate.
Dosage

10 milligrams of neomycin sulfate per pound of body weight per day (22 milligrams per kilogram) in divided doses for a maximum of 14 days.

Limitations

Add powder to drinking water or milk; not for use in liquid supplements. Prepare a fresh solution in drinking water daily. If symptoms persist after using this preparation for 2 or 3 days, consult a veterinarian. Treatment should continue 24-48 hours beyond remission of disease symptoms, but not to exceed a total of 14 consecutive days. Discontinue treatment 1 day prior to slaughter in cattle. A withdrawal period has not been established for use in preruminating calves. Do not use in calves to be processed for veal. Use of more than one product containing neomycin or failure to follow withdrawal times may result in illegal drug residues. Federal Law restricts this drug to use by or on the order of a licensed veterinarian.

Swine
Indication

For the treatment and control of colibacillosis (bacterial enteritis) caused by Escherichia coli susceptible to neomycin sulfate.

Dosage

10 milligrams of neomycin sulfate per pound of body weight per day (22 milligrams per kilogram) in divided doses for a maximum of 14 days.

Limitations

Add powder to drinking water or milk; not for use in liquid supplements. Prepare a fresh solution in drinking water daily. If symptoms persist after using this preparation for 2 or 3 days, consult a veterinarian. Treatment should continue 24-48 hours beyond remission of disease symptoms, but not to exceed a total of 14 consecutive days. Discontinue treatment 3 days prior to slaughter in swine. Use of more than one product containing neomycin or failure to follow withdrawal times may result in illegal drug residues. Federal Law restricts this drug to use by or on the order of a licensed veterinarian.

Sheep
Indication
For the treatment and control of colibacillosis (bacterial enteritis) caused by Escherichia coli susceptible to neomycin sulfate.
Dosage

10 milligrams of neomycin sulfate per pound of body weight per day (22 milligrams per kilogram) in divided doses for a maximum of 14 days.

Limitations

Add powder to drinking water or milk; not for use in liquid supplements. Prepare a fresh solution in drinking water daily. If symptoms persist after using this preparation for 2 or 3 days, consult a veterinarian. Treatment should continue 24-48 hours beyond remission of disease symptoms, but not to exceed a total of 14 consecutive days. Discontinue treatment 2 days prior to slaughter in sheep. Use of more than one product containing neomycin or failure to follow withdrawal times may result in illegal drug residues. Federal Law restricts this drug to use by or on the order of a licensed veterinarian.

Goats
Indication
For the treatment and control of colibacillosis (bacterial enteritis) caused by Escherichia coli susceptible to neomycin sulfate.
Dosage

10 milligrams of neomycin sulfate per pound of body weight per day (22 milligrams per kilogram) in divided doses for a maximum of 14 days.

Limitations

Add powder to drinking water or milk; not for use in liquid supplements. Prepare a fresh solution in drinking water daily. If symptoms persist after using this preparation for 2 or 3 days, consult a veterinarian. Treatment should continue 24-48 hours beyond remission of disease symptoms, but not to exceed a total of 14 consecutive days. Discontinue treatment 3 days prior to slaughter in goats. Use of more than one product containing neomycin or failure to follow withdrawal times may result in illegal drug residues. Federal Law restricts this drug to use by or on the order of a licensed veterinarian.

FDA page: Open in Animal Drugs @ FDA

Species: Dog, No Use Class Stated Or Implied • Cat, No Use Class Stated Or Implied
Composition / specifications
Each milliliter of petrolatum base or each gram of vanishing cream base ointment contains: 100,000 units of nystatin; neomycin sulfate equivalent to 2.5 milligrams of neomycin base; 2,500 units of thiostrepton; and 1.0 milligram of triamcinolone acetonide.
Cats
Indication
Topically: Use either ointment in dogs and cats for anti-inflammatory, antipruritic, antifungal, and antibacterial treatment of superficial bacterial infections, and for dermatologic disorders characterized by inflammation and dry or exudative dermatitis, particularly associated with bacterial or candidal (Candida albicans) infections.
Dosage
For topical dermatological use: Clean affected areas and remove any encrusted discharge or exudate, and apply sparingly either ointment in a thin film.
Limitations
For mild inflammations, use once daily to once a week. For severe conditions, apply initially two to three times daily, decreasing frequency as improvement occurs. Not intended for treatment of deep abscesses or deep-seated infections. Not for ophthalmic use. Federal law restricts this drug to use by or on the order of a licensed veterinarian.
Dogs
Indication
Topically: Use either ointment in dogs and cats for anti-inflammatory, antipruritic, antifungal, and antibacterial treatment of superficial bacterial infections, and for dermatologic disorders characterized by inflammation and dry or exudative dermatitis, particularly associated with bacterial or candidal (Candida albicans) infections.
Dosage
For topical dermatological use: Clean affected areas and remove any encrusted discharge or exudate, and apply sparingly either ointment in a thin film.
Limitations
For mild inflammations, use once daily to once a week. For severe conditions, apply initially two to three times daily, decreasing frequency as improvement occurs. Not intended for treatment of deep abscesses or deep-seated infections. Not for ophthalmic use. Federal law restricts this drug to use by or on the order of a licensed veterinarian.

FDA page: Open in Animal Drugs @ FDA

Species: Goat, No Use Class Stated Or Implied • No use class stated or implied • Cattle, Excluding Veal Calves • Growing • Sheep, No Use Class Stated Or Implied
Composition / specifications
The drug contains 20.3 grams of neomycin sulfate per ounce which is equivalent to 14.2 grams of neomycin base.
Cattle (excluding veal calves)
Indication
For the treatment and control of colibacillosis (bacterial enteritis) caused by Escherichia coli susceptible to neomycin sulfate in cattle (excluding veal calves).
Dosage
10 milligrams of neomycin sulfate per pound of body weight per day (22 milligrams per kilogram) in divided doses for a maximum of 14 days.
Limitations

Add to drinking water or milk. Not for use in liquid supplements. Prepare a fresh solution daily. If symptoms persist after using this preparation for 2 or 3 days, consult a veterinarian. Treatment should continue 24-48 hours beyond remission of disease symptoms, but not to exceed a total of 14 days. Discontinue treatment 1 day prior to slaughter in cattle (not for use in veal calves).

Federal Law restricts this drug to use by or on the order of a licensed veterinarian.

Sheep
Indication

For the treatment and control of colibacillosis (bacterial enteritis) caused by Escherichia coli susceptible to neomycin sulfate in sheep.

Dosage
10 milligrams of neomycin sulfate per pound of body weight per day (22 milligrams per kilogram) in divided doses for a maximum of 14 days.
Limitations

Add to drinking water or milk. Not for use in liquid supplements. Prepare a fresh solution daily. If symptoms persist after using this preparation for 2 or 3 days, consult a veterinarian. Treatment should continue 24-48 hours beyond remission of disease symptoms, but not to exceed a total of 14 days. Discontinue treatment 2 days prior to slaughter in sheep.

Federal Law restricts this drug to use by or on the order of a licensed veterinarian.

Swine
Indication
For the treatment and control of colibacillosis (bacterial enteritis) caused by Escherichia coli susceptible to neomycin sulfate in swine.
Dosage
10 milligrams of neomycin sulfate per pound of body weight per day (22 milligrams per kilogram) in divided doses for a maximum of 14 days.
Limitations

Add to drinking water or milk. Not for use in liquid supplements. Prepare a fresh solution daily. If symptoms persist after using this preparation for 2 or 3 days, consult a veterinarian. Treatment should continue 24-48 hours beyond remission of disease symptoms, but not to exceed a total of 14 days. Discontinue treatment 3 days prior to slaughter in swine.

Federal Law restricts this drug to use by or on the order of a licensed veterinarian.

Goats
Indication
For the treatment and control of colibacillosis (bacterial enteritis) caused by Escherichia coli susceptible to neomycin sulfate in goats.
Dosage
10 milligrams of neomycin sulfate per pound of body weight per day (22 milligrams per kilogram) in divided doses for a maximum of 14 days.
Limitations

Add to drinking water or milk. Not for use in liquid supplements. Prepare a fresh solution daily. If symptoms persist after using this preparation for 2 or 3 days, consult a veterinarian. Treatment should continue 24-48 hours beyond remission of disease symptoms, but not to exceed a total of 14 days. Discontinue treatment 3 days prior to slaughter in goats.

Federal Law restricts this drug to use by or on the order of a licensed veterinarian.

Turkeys (growing)
Indication

For the control of mortality associated with E. coli organisms susceptible to neomycin sulfate in growing turkeys.

Dosage

10 milligrams of neomycin sulfate per pound of body weight per day (22 milligrams per kilogram) for 5 days.

Limitations

Add to drinking water. Not for use in liquid supplements. Prepare a fresh solution daily. If symptoms persist after using this preparation for 2 or 3 days, consult a veterinarian. Treatment should continue 24 to 48 hours beyond remission of disease symptoms, but not to exceed a total of 5 consecutive days.

Federal Law restricts this drug to use by or on the order of a licensed veterinarian.

FDA page: Open in Animal Drugs @ FDA

Species: Dog, No Use Class Stated Or Implied • Cat, No Use Class Stated Or Implied
Composition / specifications
Each gram of ointment contains: polymyxin B sulfate 10,000 units, bacitracin zinc 400 units, and neomycin sulfate 5 mg (equivalent to 3.5 mg neomycin base).
Label highlights
Indication
For the treatment of superficial bacterial infections of the eyelid and conjunctiva of dogs and cats when due to organisms susceptible to one or more of the antibiotics contained in the ointment
Dosage
Apply a thin film over the cornea 3 or 4 times daily
Limitations
Federal law restricts this drug to use by or on the order of a licensed veterinarian

FDA page: Open in Animal Drugs @ FDA

Species: Dog, No Use Class Stated Or Implied • Cat, No Use Class Stated Or Implied
Composition / specifications
Prednisolone sodium phosphate-neomycin sulfate ophthalmic ointment contains prednisolone sodium phosphate equivalent to 2.5 milligrams prednisolone 21-phosphate and 5 milligrams neomycin sulfate (equivalent to 3.5 milligrams neomycin base) in each gram of ointment.
Cats
Indication
The drug is recommended for use in superficial ocular inflammations or infections limited to the conjunctiva or the anterior segment of the eye of cats, such as those associated with allergic reactions or gross irritants.
Dosage
A small quantity of the ointment should be expressed into the conjunctival sac 4 times a day (at intervals of 1 to 8 hours) for a few days until there is a favorable response, then the frequency of application may be reduced to twice daily as long as the condition remains under control. Treatment may require from a few days to several weeks.
Limitations
All topical ophthalmic preparations containing corticosteroids with or without an antimicrobial agent are contraindicated in the initial treatment of corneal ulcers. They should not be used until the infection is under control and corneal regeneration is well underway. For use only by or on the order of a licensed veterinarian.
Dogs
Indication
The drug is recommended for use in superficial ocular inflammations or infections limited to the conjunctiva or the anterior segment of the eye of dogs, such as those associated with allergic reactions or gross irritants.
Dosage
A small quantity of the ointment should be expressed into the conjunctival sac 4 times a day (at intervals of 1 to 8 hours) for a few days until there is a favorable response, then the frequency of application may be reduced to twice daily as long as the condition remains under control. Treatment may require from a few days to several weeks.
Limitations
All topical ophthalmic preparations containing corticosteroids with or without an antimicrobial agent are contraindicated in the initial treatment of corneal ulcers. They should not be used until the infection is under control and corneal regeneration is well underway. For use only by or on the order of a licensed veterinarian.

FDA page: Open in Animal Drugs @ FDA

Species: Dog, No Use Class Stated Or Implied • Horse, No Use Class Stated Or Implied • Cat, No Use Class Stated Or Implied
Composition / specifications
NEO-PREDEF with Tetracaine Powder contains in each gram neomycin sulfate, 5 mg (equivalent to 3.5 mg neomycin); isoflupredone acetate, 1 mg; tetracaine hydrochloride, 5 mg; myristyl-gamma-picolinium chloride (as a preservative); and lactose hydrous.
Dogs, cats, and horses
Indication

Indicated in the treatment or adjunctive therapy of certain ear and skin conditions in dogs, cats and horses caused by or associated with neomycin-susceptible organisms and/or allergy. In addition, it is indicated as superficial dressing applied to minor cuts, wounds, lacerations, abrasions, and for post-surgical application where reduction of pain and inflammatory response is deemed desirable. NEO-PREDEF with Tetracaine Powder may be used as a dusting powder following amputation of tails, claws, and dew-claws; following ear trimming and castrating; and following such surgical procedure as ovariohysterectomies. Applied superficially, it has been used successfully in the treatment of acute otitis externa in dogs, acute moist dermatitis and interdigital dermatitis in the dog, and as a dusting powder to various minor cuts, lacerations, and abrasions in the horse, cat and dog.

Dosage

After cleaning the affected area, NEO-PREDEF with Tetracaine Powder is applied by compressing the sides of the container with short, sharp squeezes. In the most instances a single daily application will be sufficient; however, it may be applied one to three times daily, as required.

Limitations

FDA page: Open in Animal Drugs @ FDA

Species: Goat, No Use Class Stated Or Implied • No use class stated or implied • Cattle, Excluding Veal Calves • Growing • Sheep, No Use Class Stated Or Implied
Composition / specifications
Each ounce of powder contains 20.3 grams of neomycin sulfate (equivalent to 14.2 grams of neomycin base).
Turkeys (growing)
Indication

For the control of mortality associated with E. coli organisms susceptible to neomycin sulfate in growing turkeys.

Dosage
10 milligrams of neomycin sulfate per pound of body weight per day (22 milligrams per kilogram) for 5 days.
Limitations

Add to drinking water. Not for use in liquid supplements. Prepare a fresh solution daily. If symptoms persist after using this preparation for 2 or 3 days, consult a veterinarian. Treatment should continue 24 to 48 hours beyond remission of disease symptoms, but not to exceed a total of 5 consecutive days. Use of more than one product containing neomycin or failure to follow withdrawal times may result in illegal drug residues. Federal Law restricts this drug to use by or on the order of a licensed veterinarian.

Sheep
Indication

For the treatment and control of colibacillosis (bacterial enteritis) caused by Escherichia coli susceptible to neomycin sulfate in sheep.

Dosage

10 milligrams of neomycin sulfate per pound of body weight per day (22 milligrams per kilogram) in divided doses for a maximum of 14 days.

Limitations

Add to drinking water. Not for use in liquid supplements. Prepare a fresh solution daily. If symptoms persist after using this preparation for 2 or 3 days, consult a veterinarian. Treatment should continue 24-48 hours beyond remission of disease symptoms, but not to exceed a total of 14 days. Discontinue treatment 2 days prior to slaughter in sheep. Use of more than one product containing neomycin or failure to follow withdrawal times may result in illegal drug residues. Federal law restricts this drug to use by or on the order of a licensed veterinarian.

Swine
Indication

For the treatment and control of colibacillosis (bacterial enteritis) caused by Escherichia coli susceptible to neomycin sulfate in swine.

Dosage

10 milligrams of neomycin sulfate per pound of body weight per day (22 milligrams per kilogram) in divided doses for a maximum of 14 days.

Limitations

Add to drinking water. Not for use in liquid supplements. Prepare a fresh solution daily. If symptoms persist after using this preparation for 2 or 3 days, consult a veterinarian. Treatment should continue 24-48 hours beyond remission of disease symptoms, but not to exceed a total of 14 days. Discontinue treatment 3 days prior to slaughter in swine. Use of more than one product containing neomycin or failure to follow withdrawal times may result in illegal drug residues. Federal law restricts this drug to use by or on the order of a licensed veterinarian.

Goats
Indication

For the treatment and control of colibacillosis (bacterial enteritis) caused by Escherichia coli susceptible to neomycin sulfate in goats.

Dosage

10 milligrams of neomycin sulfate per pound of body weight per day (22 milligrams per kilogram) in divided doses for a maximum of 14 days.

Limitations

Add to drinking water. Not for use in liquid supplements. Prepare a fresh solution daily. If symptoms persist after using this preparation for 2 or 3 days, consult a veterinarian. Treatment should continue 24-48 hours beyond remission of disease symptoms, but not to exceed a total of 14 days. Discontinue treatment 3 days prior to slaughter in goats. Use of more than one product containing neomycin or failure to follow withdrawal times may result in illegal drug residues. Federal law restricts this drug to use by or on the order of a licensed veterinarian.

Cattle (excluding veal calves)
Indication

For the treatment and control of colibacillosis (bacterial enteritis) caused by Escherichia coli susceptible to neomycin sulfate in cattle (excluding veal calves).

Dosage

10 milligrams of neomycin sulfate per pound of body weight per day (22 milligrams per kilogram) in divided doses for a maximum of 14 days.

Limitations

Add to drinking water. Not for use in liquid supplements. Prepare a fresh solution daily. If symptoms persist after using this preparation for 2 or 3 days, consult a veterinarian. Treatment should continue 24-48 hours beyond remission of disease symptoms, but not to exceed a total of 14 days. Discontinue treatment 1 day prior to slaughter in cattle. A withdrawal period has not been established for use in preruminating calves. Do not use in calves to be processed for veal. Use of more than one product containing neomycin or failure to follow withdrawal times may result in illegal drug residues. Federal law restricts this drug to use by or on the order of a licensed veterinarian.

FDA page: Open in Animal Drugs @ FDA

Species: Dog, No Use Class Stated Or Implied • Cat, No Use Class Stated Or Implied
Composition / specifications
Each milliliter of petrolatum base or each gram of vanishing cream base ointment contains: 100,000 units of nystatin; neomycin sulfate equivalent to 2.5 milligrams of neomycin base; 2,500 units of thiostrepton; and 1.0 milligram of triamcinolone acetonide.
Cats
Indication
Topically: Use either ointment in dogs and cats for anti-inflammatory, antipruritic, antifungal, and antibacterial treatment of superficial bacterial infections, and for dermatologic disorders characterized by inflammation and dry or exudative dermatitis, particularly associated with bacterial or candidal (Candida albicans) infections.
Dosage
For topical dermatological use: Clean affected areas and remove any encrusted discharge or exudate, and apply sparingly either ointment in a thin film.
Limitations
For mild inflammations, use once daily to once a week. For severe conditions, apply initially two to three times daily, decreasing frequency as improvement occurs. Not intended for treatment of deep abscesses or deep-seated infections. Not for ophthalmic use. Federal law restricts this drug to use by or on the order of a licensed veterinarian.
Dogs
Indication
Topically: Use either ointment in dogs and cats for anti-inflammatory, antipruritic, antifungal, and antibacterial treatment of superficial bacterial infections, and for dermatologic disorders characterized by inflammation and dry or exudative dermatitis, particularly associated with bacterial or candidal (Candida albicans) infections.
Dosage
For topical dermatological use: Clean affected areas and remove any encrusted discharge or exudate, and apply sparingly either ointment in a thin film.
Limitations
For mild inflammations, use once daily to once a week. For severe conditions, apply initially two to three times daily, decreasing frequency as improvement occurs. Not intended for treatment of deep abscesses or deep-seated infections. Not for ophthalmic use. Federal law restricts this drug to use by or on the order of a licensed veterinarian.

FDA page: Open in Animal Drugs @ FDA

Species: Goat, No Use Class Stated Or Implied • No use class stated or implied • Cattle, Excluding Veal Calves • Sheep, No Use Class Stated Or Implied
Composition / specifications
Each milliliter contains 200 milligrams of neomycin sulfate (equivalent to 140 milligrams of neomycin base).
Cattle (excluding veal calves)
Indication

For the treatment and control of colibacillosis (bacterial enteritis) caused by Escherichia coli susceptible to neomycin sulfate in cattle (excluding veal calves).

Dosage

10 milligrams of neomycin sulfate per pound of body weight per day(22 milligrams per kilogram) in divided doses for a maximum of 14 days.

Limitations

Add to drinking water. Not for use in liquid supplements. Prepare a fresh solution daily. If symptoms persist after using this preparation for 2 or 3 days, consult a veterinarian. Treatment should continue 24-48 hours beyond remission of disease symptoms, but not to exceed a total of 14 days. Discontinue treatment 1 day prior to slaughter in cattle. A withdrawal period has not been established for use in preruminating calves. Do not use in calves to be processed for veal. Use of more than one product containing neomycin or failure to follow withdrawal times may result in illegal drug residues. Federal law restricts this drug to use by or on the order of a licensed veterinarian.

Sheep
Indication

For the treatment and control of colibacillosis (bacterial enteritis) caused by Escherichia coli susceptible to neomycin sulfate in sheep.

Dosage

10 milligrams of neomycin sulfate per pound of body weight per day (22 milligrams per kilogram) in divided doses for a maximum of 14 days.

Limitations

Add to drinking water. Not for use in liquid supplements. Prepare a fresh solution daily. If symptoms persist after using this preparation for 2 or 3 days, consult a veterinarian. Treatment should continue 24-48 hours beyond remission of disease symptoms, but not to exceed a total of 14 days. Discontinue treatment 2 days prior to slaughter in sheep. Use of more than one product containing neomycin or failure to follow withdrawal times may result in illegal drug residues. Federal law restricts this drug to use by or on the order of a licensed veterinarian.

Swine
Indication

For the treatment and control of colibacillosis (bacterial enteritis) caused by Escherichia coli susceptible to neomycin sulfate in swine.

Dosage

10 milligrams of neomycin sulfate per pound of body weight per day (22 milligrams per kilogram) in divided doses for a maximum of 14 days.

Limitations

Add to drinking water. Not for use in liquid supplements. Prepare a fresh solution daily. If symptoms persist after using this preparation for 2 or 3 days, consult a veterinarian. Treatment should continue 24-48 hours beyond remission of disease symptoms, but not to exceed a total of 14 days. Discontinue treatment 3 days prior to slaughter in swine. Use of more than one product containing neomycin or failure to follow withdrawal times may result in illegal drug residues. Federal law restricts this drug to use by or on the order of a licensed veterinarian.

Goats
Indication

For the treatment and control of colibacillosis (bacterial enteritis) caused by Escherichia coli susceptible to neomycin sulfate in goats.

Dosage

Amount: 10 milligrams of neomycin sulfate per pound of body weight per day (22 milligrams per kilogram) in divided doses for a maximum of 14 days.

Limitations

Add to drinking water. Not for use in liquid supplements. Prepare a fresh solution daily. If symptoms persist after using this preparation for 2 or 3 days, consult a veterinarian. Treatment should continue 24-48 hours beyond remission of disease symptoms, but not to exceed a total of 14 days. Discontinue treatment 3 days prior to slaughter in goats. Use of more than one product containing neomycin or failure to follow withdrawal times may result in illegal drug residues. Federal law restricts this drug to use by or on the order of a licensed veterinarian.

FDA page: Open in Animal Drugs @ FDA

Species: Goat, No Use Class Stated Or Implied • No use class stated or implied • Cattle, Excluding Veal Calves • Sheep, No Use Class Stated Or Implied
Composition / specifications
Each milliliter contains 200 milligrams of neomycin sulfate (equivalent to 140 milligrams of neomycin base).
Cattle (excluding veal calves)
Indication

For the treatment and control of colibacillosis (bacterialenteritis) caused by Escherichia coli susceptible to neomycin sulfate incattle (excluding veal calves).

Dosage

10 milligrams of neomycin sulfate per pound of body weight per day (22 milligrams per kilogram) in divided doses for a maximum of 14 days.

Limitations

Add to drinking water. Not for use in liquid supplements. Prepare a fresh solution daily. If symptoms persist after using this preparation for 2 or 3 days, consult a veterinarian. Treatment should continue 24-48 hours beyond remission of disease symptoms, but not to exceed a total of 14 days. Discontinue treatment 1 day prior to slaughter in cattle. A withdrawal period has not been established for use in preruminating calves. Do not use in calves to be processed for veal. Use of more than one product containing neomycin or failure to follow withdrawal times may result in illegal drug residues. Federal law restricts this drug to use by or on the order of a licensed veterinarian.

Sheep
Indication

For the treatment and control of colibacillosis (bacterial enteritis) caused by Escherichia coli susceptible to neomycin sulfate in sheep.

Dosage

10 milligrams of neomycin sulfate per pound of body weight per day (22 milligrams per kilogram) in divided doses for a maximum of 14 days.

Limitations

Add to drinking water. Not for use in liquid supplements. Prepare a fresh solution daily. If symptoms persist after using this preparation for 2 or 3 days, consult a veterinarian. Treatment should continue 24-48 hours beyond remission of disease symptoms, but not to exceed a total of 14 days. Discontinue treatment 2 days prior to slaughter in sheep. Use of more than one product containing neomycin or failure to follow withdrawal times may result in illegal drug residues. Federal law restricts this drug to use by or on the order of a licensed veterinarian.

Swine
Indication

For the treatment and control of colibacillosis (bacterial enteritis) caused by Escherichia coli susceptible to neomycin sulfate in swine. 

Dosage

10 milligrams of neomycin sulfate per pound of body weight per day (22 milligrams per kilogram) in divided doses for a maximum of 14 days.

Limitations

Add to drinking water. Not for use in liquid supplements. Prepare a fresh solution daily. If symptoms persist after using this preparation for 2 or 3 days, consult a veterinarian. Treatment should continue 24-48 hours beyond remission of disease symptoms, but not to exceed a total of 14 days. Discontinue treatment 3 days prior to slaughter in swine. Use of more than one product containing neomycin or failure to follow withdrawal times may result in illegal drug residues. Federal law restricts this drug to use by or on the order of a licensed veterinarian.

Goats
Indication

For the treatment and control of colibacillosis (bacterial enteritis) caused by Escherichia coli susceptible to neomycin sulfate in goats.

Dosage

10 milligrams of neomycin sulfate per pound of body weight per day (22 milligrams per kilogram) in divided doses for a maximum of 14 days.

Limitations

Add to drinking water. Not for use in liquid supplements. Prepare a fresh solution daily. If symptoms persist after using this preparation for 2 or 3 days, consult a veterinarian. Treatment should continue 24-48 hours beyond remission of disease symptoms, but not to exceed a total of 14 days. Discontinue treatment 3 days prior to slaughter in goats. Use of more than one product containing neomycin or failure to follow withdrawal times may result in illegal drug residues. Federal law restricts this drug to use by or on the order of a licensed veterinarian.

FDA page: Open in Animal Drugs @ FDA

Species: Goat, No Use Class Stated Or Implied • No use class stated or implied • Cattle, Excluding Veal Calves • Sheep, No Use Class Stated Or Implied
Composition / specifications
The drug contains 20.3 grams of neomycin sulfate per ounce which is equivalent to 14.2 grams of neomycin base.
Cattle (excluding veal calves)
Indication
For the treatment and control of colibacillosis (bacterial enteritis) caused by Escherichia coli susceptible to neomycin sulfate.
Dosage
10 milligrams of neomycin sulfate per pound of body weight per day in divided doses for a maximum of 14 days.
Limitations

Add to drinking water or milk. Not for use in liquid supplements. Prepare a fresh solution daily. If symptoms persist after using this preparation for 2 or 3 days, consult a veterinarian. Treatment should continue 24 to 48 hours beyond remission of disease symptoms, but not to exceed a total of 14 consecutive days. Withdraw 1 day before slaughter. 

Federal Law restricts this drug to use by or on the order of a licensed veterinarian.

Swine
Indication
For the treatment and control of colibacillosis (bacterial enteritis) caused by Escherichia coli susceptible to neomycin sulfate.
Dosage
10 milligrams of neomycin sulfate per pound of body weight per day in divided doses for a maximum of 14 days.
Limitations

Add to drinking water or milk. Not for use in liquid supplements. Prepare a fresh solution daily. If symptoms persist after using this preparation for 2 or 3 days, consult a veterinarian. Treatment should continue 24 to 48 hours beyond remission of disease symptoms, but not to exceed a total of 14 consecutive days. Withdraw 3 days before slaughter. 

Federal Law restricts this drug to use by or on the order of a licensed veterinarian.

Sheep
Indication
For the treatment and control of colibacillosis (bacterial enteritis) caused by Escherichia coli susceptible to neomycin sulfate.
Dosage
10 milligrams of neomycin sulfate per pound of body weight per day in divided doses for a maximum of 14 days.
Limitations

Add to drinking water or milk. Not for use in liquid supplements. Prepare a fresh solution daily. If symptoms persist after using this preparation for 2 or 3 days, consult a veterinarian. Treatment should continue 24 to 48 hours beyond remission of disease symptoms, but not to exceed a total of 14 consecutive days. Withdraw 2 days before slaughter. 

Federal Law restricts this drug to use by or on the order of a licensed veterinarian.

Goats
Indication
For the treatment and control of colibacillosis (bacterial enteritis) caused by Escherichia coli susceptible to neomycin sulfate.
Dosage
10 milligrams of neomycin sulfate per pound of body weight per day in divided doses for a maximum of 14 days.
Limitations

Add to drinking water or milk. Not for use in liquid supplements. Prepare a fresh solution daily. If symptoms persist after using this preparation for 2 or 3 days, consult a veterinarian. Treatment should continue 24 to 48 hours beyond remission of disease symptoms, but not to exceed a total of 14 consecutive days. Withdraw 3 days before slaughter. 

Federal Law restricts this drug to use by or on the order of a licensed veterinarian.

FDA page: Open in Animal Drugs @ FDA

Species: Goat, No Use Class Stated Or Implied • No use class stated or implied • Cattle, Excluding Veal Calves • Sheep, No Use Class Stated Or Implied
Composition / specifications
Each milliliter contains 200 milligrams of neomycin sulfate (equivalent to 140 milligrams of neomycin base).
Cattle (excluding veal calves)
Indication
For the treatment and control of colibacillosis (bacterial enteritis) caused by Escherichia coli susceptible to neomycin.
Dosage
10 milligrams of neomycin sulfate per pound of body weight per day in divided doses for a maximum of 14 days.
Limitations

Administer undiluted or in drinking water. Prepare a fresh solution daily. If symptoms persist after using this preparation for 2 or 3 days, consult a veterinarian. Treatment should continue 24 to 48 hours beyond remission of disease symptoms, but not to exceed a total of 14 consecutive days. Discontinue treatment 1 day prior to slaughter. Federal Law restricts this drug to use by or on the order of a licensed veterinarian.

Swine
Indication
For the treatment and control of colibacillosis (bacterial enteritis) caused by Escherichia coli susceptible to neomycin.
Dosage
10 milligrams of neomycin sulfate per pound of body weight per day in divided doses for a maximum of 14 days.
Limitations

Administer undiluted or in drinking water. Prepare a fresh solution daily. If symptoms persist after using this preparation for 2 or 3 days, consult a veterinarian. Treatment should continue 24 to 48 hours beyond remission of disease symptoms, but not to exceed a total of 14 consecutive days. Discontinue treatment 3 days prior to slaughter. Federal Law restricts this drug to use by or on the order of a licensed veterinarian.

Sheep
Indication
For the treatment and control of colibacillosis (bacterial enteritis) caused by Escherichia coli susceptible to neomycin.
Dosage
10 milligrams of neomycin sulfate per pound of body weight per day in divided doses for a maximum of 14 days.
Limitations

Administer undiluted or in drinking water. Prepare a fresh solution daily. If symptoms persist after using this preparation for 2 or 3 days, consult a veterinarian. Treatment should continue 24 to 48 hours beyond remission of disease symptoms, but not to exceed a total of 14 consecutive days. Discontinue treatment 2 days prior to slaughter.  Federal Law restricts this drug to use by or on the order of a licensed veterinarian.

Goats
Indication
For the treatment and control of colibacillosis (bacterial enteritis) caused by Escherichia coli susceptible to neomycin.
Dosage
10 milligrams of neomycin sulfate per pound of body weight per day in divided doses for a maximum of 14 days.
Limitations

Administer undiluted or in drinking water. Prepare a fresh solution daily. If symptoms persist after using this preparation for 2 or 3 days, consult a veterinarian. Treatment should continue 24 to 48 hours beyond remission of disease symptoms, but not to exceed a total of 14 consecutive days. Discontinue treatment 3 days prior to slaughter. Federal Law restricts this drug to use by or on the order of a licensed veterinarian.

FDA page: Open in Animal Drugs @ FDA

Species: Dog, No Use Class Stated Or Implied • Cat, No Use Class Stated Or Implied
Composition / specifications
Each milliliter contains: 100,000 units of nystatin; neomycin sulfate equivalent to 2.5 milligrams of neomycin base; 2,500 units of thiostrepton; and 1.0 milligram of triamcinolone acetonide.
Cats
Indication
For topical dermatological use. Use either ointment for anti-inflammatory, antipruritic, antifungal, and antibacterial treatment of superficial bacterial infections, and for dermatologic disorders characterized by inflammation and dry or exudative dermatitis, particularly associated with bacterial or candidal (Candida albicans) infections.
Dosage
For mild inflammations, application may range from once daily to once a week; for severe conditions Animax Ointment may be applied as often as two to three times daily, if necessary. Frequency of treatment may be decreased as improvement occurs.
Limitations
Not intended for treatment of deep abscesses or deep-seated infections. Not for ophthalmic use. Federal law restricts this drug to use by or on the order of a licensed veterinarian.
Indication
For otic use. Use petrolatum base ointment for the treatment of acute and chronic otitis.
Dosage
For mild inflammations, application may range from once daily to once a week; for severe conditions Animax Ointment may be applied as often as two to three times daily, if necessary. Frequency of treatment may be decreased as improvement occurs.
Limitations
Not intended for treatment of deep abscesses or deep-seated infections. Not for ophthalmic use. Federal law restricts this drug to use by or on the order of a licensed veterinarian.
Indication
For cystic areas. Use petrolatum base ointment for the treatment of interdigital cysts and for anal gland infections.
Dosage
For mild inflammations, application may range from once daily to once a week; for severe conditions Animax Ointment may be applied as often as two to three times daily, if necessary. Frequency of treatment may be decreased as improvement occurs.
Limitations
Not intended for treatment of deep abscesses or deep-seated infections. Not for ophthalmic use. Federal law restricts this drug to use by or on the order of a licensed veterinarian.
Dogs
Indication
For infected anal glands and cystic areas. Use petrolatum base ointment for the treatment of interdigital cysts and for anal gland infections.
Dosage
For mild inflammations, application may range from once daily to once a week; for severe conditions Animax Ointment may be applied as often as two to three times daily, if necessary. Frequency of treatment may be decreased as improvement occurs.
Limitations
Not intended for treatment of deep abscesses or deep-seated infections. Not for ophthalmic use. Federal law restricts this drug to use by or on the order of a licensed veterinarian.
Indication
For topical dermatological use. Use either ointment for anti-inflammatory, antipruritic, antifungal, and antibacterial treatment of superficial bacterial infections, and for dermatologic disorders characterized by inflammation and dry or exudative dermatitis, particularly associated with bacterial or candidal (Candida albicans) infections.
Dosage
For mild inflammations, application may range from once daily to once a week; for severe conditions Animax Ointment may be applied as often as two to three times daily, if necessary. Frequency of treatment may be decreased as improvement occurs.
Limitations
Not intended for treatment of deep abscesses or deep-seated infections. Not for ophthalmic use. Federal law restricts this drug to use by or on the order of a licensed veterinarian.
Indication
For otic use. Use petrolatum base ointment for the treatment of acute and chronic otitis.
Dosage
For mild inflammations, application may range from once daily to once a week; for severe conditions Animax Ointment may be applied as often as two to three times daily, if necessary. Frequency of treatment may be decreased as improvement occurs.
Limitations
Not intended for treatment of deep abscesses or deep-seated infections. Not for ophthalmic use. Federal law restricts this drug to use by or on the order of a licensed veterinarian.

FDA page: Open in Animal Drugs @ FDA

Species: Dog, No Use Class Stated Or Implied • Cat, No Use Class Stated Or Implied
Composition / specifications
Each milliliter of petrolatum base or each gram of vanishing cream base ointment contains: 100,000 units of nystatin; neomycin sulfate equivalent to 2.5 milligrams of neomycin base; 2,500 units of thiostrepton; and 1.0 milligram of triamcinolone acetonide.
Cats
Indication
For cystic areas. Use petrolatum base ointment for the treatment of interdigital cysts.
Dosage
Drain cyst and fill with petrolatum base ointment. For mild inflammations, use once daily to once a week. For severe conditions, apply initially two to three times daily, decreasing frequency as improvement occurs.
Limitations
Not intended for treatment of deep abscesses or deep-seated infections. Not for ophthalmic use. Federal law restricts this drug to use by or on the order of a licensed veterinarian.
Indication
For topical dermatological use. Use either ointment for anti-inflammatory, antipruritic, antifungal, and antibacterial treatment of superficial bacterial infections, and for dermatologic disorders characterized by inflammation and dry or exudative dermatitis, particularly associated with bacterial or candidal (Candida albicans) infections.
Dosage
Clean affected areas and remove any encrusted discharge or exudate, and apply sparingly either ointment in a thin film. For mild inflammations, use once daily to once a week. For severe conditions, apply initially two to three times daily, decreasing frequency as improvement occurs.
Limitations
Not intended for treatment of deep abscesses or deep-seated infections. Not for ophthalmic use. Federal law restricts this drug to use by or on the order of a licensed veterinarian.
Indication
For otic use. Use petrolatum base ointment for the treatment of acute and chronic otitis.
Dosage
Clean ear canal of impacted cerumen, remove any foreign bodies such as grass awns and ticks, and instill three to five drops of petrolatum base ointment. Preliminary use of a local anesthetic may be advisable. For mild inflammations, use once daily to once a week. For severe conditions, apply initially two to three times daily, decreasing frequency as improvement occurs.
Limitations
Not intended for treatment of deep abscesses or deep-seated infections. Not for ophthalmic use. Federal law restricts this drug to use by or on the order of a licensed veterinarian.
Dogs
Indication
For topical dermatological use. Use either ointment for anti-inflammatory, antipruritic, antifungal, and antibacterial treatment of superficial bacterial infections, and for dermatologic disorders characterized by inflammation and dry or exudative dermatitis, particularly associated with bacterial or candidal (Candida albicans) infections.
Dosage
Clean affected areas and remove any encrusted discharge or exudate, and apply sparingly either ointment in a thin film. For mild inflammations, use once daily to once a week. For severe conditions, apply initially two to three times daily, decreasing frequency as improvement occurs.
Limitations
Not intended for treatment of deep abscesses or deep-seated infections. Not for ophthalmic use. Federal law restricts this drug to use by or on the order of a licensed veterinarian.
Indication
For otic use. Use petrolatum base ointment for the treatment of acute and chronic otitis.
Dosage
Clean ear canal of impacted cerumen, remove any foreign bodies such as grass awns and ticks, and instill three to five drops of petrolatum base ointment. Preliminary use of a local anesthetic may be advisable. For mild inflammations, use once daily to once a week. For severe conditions, apply initially two to three times daily, decreasing frequency as improvement occurs.
Limitations
Not intended for treatment of deep abscesses or deep-seated infections. Not for ophthalmic use. Federal law restricts this drug to use by or on the order of a licensed veterinarian.
Indication
For infected anal glands and cystic areas. Use petrolatum base ointment for the treatment of interdigital cysts, and for anal gland infections.
Dosage
Drain gland or cyst and fill with petrolatum base ointment. For mild inflammations, use once daily to once a week. For severe conditions, apply initially two to three times daily, decreasing frequency as improvement occurs.
Limitations
Not intended for treatment of deep abscesses or deep-seated infections. Not for ophthalmic use. Federal law restricts this drug to use by or on the order of a licensed veterinarian.

FDA page: Open in Animal Drugs @ FDA

Species: Goat, No Use Class Stated Or Implied • No use class stated or implied • Cattle, Excluding Veal Calves • Sheep, No Use Class Stated Or Implied
Composition / specifications
Each milliliter contains 200 milligrams of neomycin sulfate (equivalent to 140 milligrams of neomycin base)
Cattle (excluding veal calves)
Indication

For the treatment and control of colibacillosis (bacterial enteritis) caused by Escherichia coli susceptible to neomycin sulfate in cattle (excluding veal calves).

Dosage

10 milligrams of neomycin sulfate per pound of body weight per day (22 milligrams per kilogram) in divided doses for a maximum of 14 days.

Limitations

Add to drinking water. Not for use in liquid supplements. Prepare a fresh solution daily. If symptoms persist after using this preparation for 2 or 3 days, consult a veterinarian. Treatment should continue 24-48 hours beyond remission of disease symptoms, but not to exceed a total of 14 days. Discontinue treatment 1 day prior to slaughter in cattle. A withdrawal period has not been established for use in preruminating calves. Do not use in calves to be processed for veal. Use of more than one product containing neomycin or failure to follow withdrawal times may result in illegal drug residues. Federal law restricts this drug to use by or on the order of a licensed veterinarian.

Sheep
Indication

For the treatment and control of colibacillosis (bacterial enteritis) caused by Escherichia coli susceptible to neomycin sulfate in sheep.

Dosage

10 milligrams of neomycin sulfate per pound of body weight per day (22 milligrams per kilogram) in divided doses for a maximum of 14 days.

Limitations

Add to drinking water. Not for use in liquid supplements. Prepare a fresh solution daily. If symptoms persist after using this preparation for 2 or 3 days, consult a veterinarian. Treatment should continue 24-48 hours beyond remission of disease symptoms, but not to exceed a total of 14 days. Discontinue treatment 2 days prior to slaughter in sheep. Use of more than one product containing neomycin or failure to follow withdrawal times may result in illegal drug residues. Federal law restricts this drug to use by or on the order of a licensed veterinarian.

Swine
Indication

For the treatment and control of colibacillosis (bacterial enteritis) caused by Escherichia coli susceptible to neomycin sulfate in swine.

Dosage

10 milligrams of neomycin sulfate per pound of body weight per day (22 milligrams per kilogram) in divided doses for a maximum of 14 days.

Limitations

Add to drinking water. Not for use in liquid supplements. Prepare a fresh solution daily. If symptoms persist after using this preparation for 2 or 3 days, consult a veterinarian. Treatment should continue 24-48 hours beyond remission of disease symptoms, but not to exceed a total of 14 days. Discontinue treatment 3 days prior to slaughter in swine. Use of more than one product containing neomycin or failure to follow withdrawal times may result in illegal drug residues. Federal law restricts this drug to use by or on the order of a licensed veterinarian.

Goats
Indication

For the treatment and control of colibacillosis (bacterial enteritis) caused by Escherichia coli susceptible to neomycin sulfate in goats. 


Dosage

10 milligrams of neomycin sulfate per pound of body weight per day (22 milligrams per kilogram) in divided doses for a maximum of 14 days.

Limitations

Add to drinking water. Not for use in liquid supplements. Prepare a fresh solution daily. If symptoms persist after using this preparation for 2 or 3 days, consult a veterinarian. Treatment should continue 24-48 hours beyond remission of disease symptoms, but not to exceed a total of 14 days. Discontinue treatment 3 days prior to slaughter in goats. Use of more than one product containing neomycin or failure to follow withdrawal times may result in illegal drug residues. Federal law restricts this drug to use by or on the order of a licensed veterinarian.

FDA page: Open in Animal Drugs @ FDA

Species: Goat, No Use Class Stated Or Implied • No use class stated or implied • Cattle, Excluding Veal Calves • Growing • Sheep, No Use Class Stated Or Implied
Composition / specifications
The drug contains 20.3 grams of neomycin sulfate per ounce which is equivalent to 14.2 grams of neomycin base.
Cattle (excluding veal calves)
Indication

For the treatment and control of colibacillosis (bacterial enteritis) caused by Escherichia coli susceptible to neomycin sulfate.

Dosage

10 milligrams of neomycin sulfate per pound of body weight per day in divided doses for a maximum of 14 days.

Limitations

Add to drinking water or milk. Not for use in liquid supplements. Prepare a fresh solution daily. If symptoms persist after using this preparation for 2 or 3 days, consult a veterinarian. Treatment should continue 24 to 48 hours beyond remission of disease symptoms, but not to exceed a total of 14 consecutive days. Discontinue treatment 1 day before slaughter. 

Federal Law restricts this drug to use by or on the order of a licensed veterinarian.

Swine
Indication

For the treatment and control of colibacillosis (bacterial enteritis) caused by Escherichia coli susceptible to neomycin sulfate.

Dosage

10 milligrams of neomycin sulfate per pound of body weight per day in divided doses for a maximum of 14 days.

Limitations

Add to drinking water or milk. Not for use in liquid supplements. Prepare a fresh solution daily. If symptoms persist after using this preparation for 2 or 3 days, consult a veterinarian. Treatment should continue 24 to 48 hours beyond remission of disease symptoms, but not to exceed a total of 14 consecutive days. Discontinue treatment 3 days before slaughter. 

Federal Law restricts this drug to use by or on the order of a licensed veterinarian.

Sheep
Indication

For the treatment and control of colibacillosis (bacterial enteritis) caused by Escherichia coli susceptible to neomycin sulfate.

Dosage

10 milligrams of neomycin sulfate per pound of body weight per day in divided doses for a maximum of 14 days.

Limitations

Add to drinking water or milk. Not for use in liquid supplements. Prepare a fresh solution daily. If symptoms persist after using this preparation for 2 or 3 days, consult a veterinarian. Treatment should continue 24 to 48 hours beyond remission of disease symptoms, but not to exceed a total of 14 consecutive days. Discontinue treatment 2 days before slaughter. 

Federal Law restricts this drug to use by or on the order of a licensed veterinarian.

Goats
Indication

For the treatment and control of colibacillosis (bacterial enteritis) caused by Escherichia coli susceptible to neomycin sulfate.

Dosage

10 milligrams of neomycin sulfate per pound of body weight per day in divided doses for a maximum of 14 days.

Limitations

Add to drinking water or milk. Not for use in liquid supplements. Prepare a fresh solution daily. If symptoms persist after using this preparation for 2 or 3 days, consult a veterinarian. Treatment should continue 24 to 48 hours beyond remission of disease symptoms, but not to exceed a total of 14 consecutive days. Discontinue treatment 3 days before slaughter. 

Federal Law restricts this drug to use by or on the order of a licensed veterinarian.

Turkeys (growing)
Indication

For the control of mortality associated with E. coli susceptible to neomycin sulfate in growing turkeys.

Dosage
10 milligrams of neomycin sulfate per pound of body weight per day (22 milligrams per kilogram) for 5 days.
Limitations

Add to drinking water. Not for use in liquid supplements. Prepare a fresh solution daily. If symptoms persist after using this preparation for 2 or 3 days, consult a veterinarian. Treatment should continue 24 to 48 hours beyond remission of disease symptoms, but not to exceed a total of 5 consecutive days. 

Federal Law restricts this drug to use by or on the order of a licensed veterinarian.

FDA page: Open in Animal Drugs @ FDA

Species: Goat, No Use Class Stated Or Implied • No use class stated or implied • Cattle, Excluding Veal Calves • Growing • Sheep, No Use Class Stated Or Implied
Composition / specifications
The drug contains 20.3 grams of neomycin sulfate per ounce which is equivalent to 14.2 grams of neomycin base.
Cattle (excluding veal calves)
Indication
For the treatment and control of colibacillosis (bacterial enteritis) caused by Escherichia coli susceptible to neomycin sulfate.
Dosage
10 milligrams of neomycin sulfate per pound of body weight per day in divided doses for a maximum of 14 days.
Limitations

Add to drinking water or milk. Not for use in liquid supplements. Prepare a fresh solution daily. If symptoms persist after using this preparation for 2 or 3 days, consult a veterinarian. Treatment should continue 24 to 48 hours beyond remission of disease symptoms, but not to exceed a total of 14 consecutive days. Discontinue treatment 1 day before slaughter.

Federal Law restricts this drug to use by or on the order of a licensed veterinarian.

Swine
Indication
For the treatment and control of colibacillosis (bacterial enteritis) caused by Escherichia coli susceptible to neomycin sulfate.
Dosage
10 milligrams of neomycin sulfate per pound of body weight per day in divided doses for a maximum of 14 days.
Limitations

Add to drinking water or milk. Not for use in liquid supplements. Prepare a fresh solution daily. If symptoms persist after using this preparation for 2 or 3 days, consult a veterinarian. Treatment should continue 24 to 48 hours beyond remission of disease symptoms, but not to exceed a total of 14 consecutive days. Discontinue treatment 3 days before slaughter.

Federal Law restricts this drug to use by or on the order of a licensed veterinarian.

Sheep
Indication
For the treatment and control of colibacillosis (bacterial enteritis) caused by Escherichia coli susceptible to neomycin sulfate.
Dosage
10 milligrams of neomycin sulfate per pound of body weight per day in divided doses for a maximum of 14 days.
Limitations

Add to drinking water or milk. Not for use in liquid supplements. Prepare a fresh solution daily. If symptoms persist after using this preparation for 2 or 3 days, consult a veterinarian. Treatment should continue 24 to 48 hours beyond remission of disease symptoms, but not to exceed a total of 14 consecutive days. Discontinue treatment 2 days before slaughter.

Federal Law restricts this drug to use by or on the order of a licensed veterinarian.

Goats
Indication
For the treatment and control of colibacillosis (bacterial enteritis) caused by Escherichia coli susceptible to neomycin sulfate.
Dosage
10 milligrams of neomycin sulfate per pound of body weight per day in divided doses for a maximum of 14 days.
Limitations

Add to drinking water or milk. Not for use in liquid supplements. Prepare a fresh solution daily. If symptoms persist after using this preparation for 2 or 3 days, consult a veterinarian. Treatment should continue 24 to 48 hours beyond remission ofdisease symptoms, but not to exceed a total of 14 consecutive days. Discontinue treatment 3 days before slaughter.

Federal Law restricts this drug to use by or on the order of a licensed veterinarian.

Turkeys (growing)
Indication

For the control of mortality associated with Escherichia coli organisms susceptible to neomycin sulfate in growing turkeys.

Federal Law restricts this drug to use by or on the order of a licensed veterinarian.


Dosage
10 milligrams of neomycin sulfate per pound of body weight per day (22 milligrams per kilogram) for 5 days.
Limitations
Add to drinking water. Not for use in liquid supplements. Prepare a fresh solution daily. If symptoms persist after using this preparation for 2 or 3 days, consult a veterinarian. Treatment should continue 24 to 48 hours beyond remission of disease symptoms, but not to exceed a total of 5 consecutive days.

FDA page: Open in Animal Drugs @ FDA

Species: Dog, No Use Class Stated Or Implied • Cat, No Use Class Stated Or Implied
Composition / specifications
Each milliliter of ophthalmic preparation contains 0.10 milligram flumethasone, 5.0 milligrams neomycin sulfate (3.5 milligrams neomycin base), and 10,000 units of polymyxin B sulfate, without hydroxypropyl methylcellulose.
Dogs
Indication
Treatment of the inflammation, edema, and secondary bacterial infections associated with topical ophthalmological conditions of the eye such as corneal injuries, incipient pannus, superficial keratitis, conjunctivitis, acute nongranulomatous anterior uveitis, kerato- conjunctivitis, and blepharitis.
Dosage
Apply 2 to 3 drops per eye, every 4 hours.
Limitations
Federal law restricts this drug to use by or on the order of a licensed veterinarian.
Cats
Indication
Treatment of the inflammation, edema, and secondary bacterial infections associated with topical ophthalmological conditions of the eye such as corneal injuries, incipient pannus, superficial keratitis, conjunctivitis, acute nongranulomatous anterior uveitis, kerato- conjunctivitis, and blepharitis.
Dosage
Apply 2 to 3 drops per eye, every 4 hours.
Limitations
Federal law restricts this drug to use by or on the order of a licensed veterinarian.

FDA page: Open in Animal Drugs @ FDA

Species: Dog, No Use Class Stated Or Implied
Composition / specifications
Each milliliter of ophthalmic preparation contains 5.0 milligrams neomycin sulfate (3.5 milligrams neomycin base), 0.10 milligram flumethasone, and 10,000 Units of polymyxin B sulfate.
Dogs
Indication
For the treatment of bacterial infections associated with topical ophthalmological conditions such as corneal injuries, superficial keratitis, conjunctivitis, keratoconjunctivitis, and blepharitis.
Dosage
Instill 1 to 2 drops per eye every 6 hours.
Limitations
Federal law restricts this drug to use by or on the order of a licensed veterinarian.

FDA page: Open in Animal Drugs @ FDA

Species: Dog, No Use Class Stated Or Implied • Cat, No Use Class Stated Or Implied
Composition / specifications
Each gram contains 400 units of bacitracin zinc, 3.5 milligrams of neomycin, and 10,000 units of polymyxin B.
Dogs
Indication
Treatment of superficial bacterial infections of the eyelid and conjunctiva of dogs and cats when due to susceptible organisms.
Dosage
Apply a thin film over the cornea 3 or 4 times daily.
Limitations
Federal law restricts this drug to use by or on the order of a licensed veterinarian.
Indication
Treatment of superficial bacterial infections of the eyelid and conjunctiva of dogs and cats when due to susceptible organisms.
Dosage
Apply a thin film over the cornea 3 or 4 times daily.
Limitations
Federal law restricts this drug to use by or on the order of a licensed veterinarian.

FDA page: Open in Animal Drugs @ FDA

Species: Dog, No Use Class Stated Or Implied • Cat, No Use Class Stated Or Implied
Composition / specifications
Each milliliter of sterile aqueous solution contains 50 milligrams of neomycin sulfate (equivalent to 35 milligrams of neomycin base).
Cats
Indication
Administer to cats for the treatment of acute and chronic bacterial infections due to organisms susceptible to neomycin.
Dosage
5 milligrams per pound of body weight daily divided into portions administered every 6 to 8 hours for 3 to 5 days. For intramuscular or intravenous use.
Limitations
Neomycin is not for use parenterally in food-producing animals because of prolonged residues in edible tissues. Labeling shall bear an appropriate expiration date. For use by or on the order of a licensed veterinarian.
Dogs
Indication
Administer to dogs for the treatment of acute and chronic bacterial infections due to organisms susceptible to neomycin.
Dosage
5 milligrams per pound of body weight daily divided into portions administered every 6 to 8 hours for 3 to 5 days. For intramuscular or intravenous use.
Limitations
Neomycin is not for use parenterally in food-producing animals because of prolonged residues in edible tissues. Labeling shall bear an appropriate expiration date. For use by or on the order of a licensed veterinarian.

FDA page: Open in Animal Drugs @ FDA

Species: Dog, No Use Class Stated Or Implied • Cat, No Use Class Stated Or Implied
Composition / specifications
Each gram of ointment contains 400 units of bacitracin zinc, 10,000 units of polymyxin B sulfate, 5 milligrams of neomycin sulfate (equivalent to 3.5 milligrams of neomycin base), and 10 milligrams of hydrocortisone.
Cats
Indication
Treating acute or chronic conjunctivitis caused by susceptible organisms.
Dosage
Apply a thin film over the cornea three or four times daily.
Limitations
Federal law restricts this drug to use by or on the order of a licensed veterinarian.
Dogs
Indication
Treating acute or chronic conjunctivitis caused by susceptible organisms.
Dosage
Apply a thin film over the cornea three or four times daily.
Limitations
Federal law restricts this drug to use by or on the order of a licensed veterinarian.

FDA page: Open in Animal Drugs @ FDA

Species: Dog, No Use Class Stated Or Implied • Cat, No Use Class Stated Or Implied
Composition / specifications
Each milliliter of petrolatum base or each gram of vanishing cream base ointment contains: 100,000 units of nystatin; neomycin sulfate equivalent to 2.5 milligrams of neomycin base; 2,500 units of thiostrepton; and 1.0 milligram of triamcinolone acetonide.
Cats
Indication
For cystic areas. Use petrolatum base ointment for the treatment of interdigital cysts.
Dosage
Drain cyst and fill with petrolatum base ointment. For mild inflammations, use once daily to once a week. For severe conditions, apply initially two to three times daily, decreasing frequency as improvement occurs.
Limitations
Not intended for treatment of deep abscesses or deep-seated infections. Not for ophthalmic use. Federal law restricts this drug to use by or on the order of a licensed veterinarian.
Indication
For otic use. Use petrolatum base ointment for the treatment of acute and chronic otitis.
Dosage
Clean ear canal of impacted cerumen, remove any foreign bodies such as grass awns and ticks, and instill three to five drops of petrolatum base ointment. Preliminary use of a local anesthetic may be advisable. For mild inflammations, use once daily to once a week. For severe conditions, apply initially two to three times daily, decreasing frequency as improvement occurs.
Limitations
Not intended for treatment of deep abscesses or deep-seated infections. Not for ophthalmic use. Federal law restricts this drug to use by or on the order of a licensed veterinarian.
Indication
For topical dermatological use. Use either ointment for anti-inflammatory, antipruritic, antifungal, and antibacterial treatment of superficial bacterial infections, and for dermatologic disorders characterized by inflammation and dry or exudative dermatitis, particularly associated with bacterial or candidal (Candida albicans) infections.
Dosage
Clean affected areas and remove any encrusted discharge or exudate, and apply sparingly either ointment in a thin film. For mild inflammations, use once daily to once a week. For severe conditions, apply initially two to three times daily, decreasing frequency as improvement occurs.
Limitations
Not intended for treatment of deep abscesses or deep-seated infections. Not for ophthalmic use. Federal law restricts this drug to use by or on the order of a licensed veterinarian.
Dogs
Indication
For infected anal glands and cystic areas. Use petrolatum base ointment for the treatment of interdigital cysts, and for anal gland infections.
Dosage
Drain gland or cyst and fill with petrolatum base ointment. For mild inflammations, use once daily to once a week. For severe conditions, apply initially two to three times daily, decreasing frequency as improvement occurs.
Limitations
Not intended for treatment of deep abscesses or deep-seated infections. Not for ophthalmic use. Federal law restricts this drug to use by or on the order of a licensed veterinarian.
Indication
For topical dermatological use. Use either ointment for anti-inflammatory, antipruritic, antifungal, and antibacterial treatment of superficial bacterial infections, and for dermatologic disorders characterized by inflammation and dry or exudative dermatitis, particularly associated with bacterial or candidal (Candida albicans) infections.
Dosage
Clean affected areas and remove any encrusted discharge or exudate, and apply sparingly either ointment in a thin film. For mild inflammations, use once daily to once a week. For severe conditions, apply initially two to three times daily, decreasing frequency as improvement occurs.
Limitations
Not intended for treatment of deep abscesses or deep-seated infections. Not for ophthalmic use. Federal law restricts this drug to use by or on the order of a licensed veterinarian.
Indication
For otic use. Use petrolatum base ointment for the treatment of acute and chronic otitis.
Dosage
Clean ear canal of impacted cerumen, remove any foreign bodies such as grass awns and ticks, and instill three to five drops of petrolatum base ointment. Preliminary use of a local anesthetic may be advisable. For mild inflammations, use once daily to once a week. For severe conditions, apply initially two to three times daily, decreasing frequency as improvement occurs.
Limitations
Not intended for treatment of deep abscesses or deep-seated infections. Not for ophthalmic use. Federal law restricts this drug to use by or on the order of a licensed veterinarian.

FDA page: Open in Animal Drugs @ FDA

Species: Dog, No Use Class Stated Or Implied • Cat, No Use Class Stated Or Implied
Composition / specifications
Each milliliter of petrolatum base or each gram of vanishing cream base ointment contains: 100,000 units of nystatin; neomycin sulfate equivalent to 2.5 milligrams of neomycin base; 2,500 units of thiostrepton; and 1.0 milligram of triamcinolone acetonide.
Cats
Indication
For topical dermatological use. Use either ointment for anti-inflammatory, antipruritic, antifungal, and antibacterial treatment of superficial bacterial infections, and for dermatologic disorders characterized by inflammation and dry or exudative dermatitis, particularly associated with bacterial or candidal (Candida albicans) infections.
Dosage
Clean affected areas and remove any encrusted discharge or exudate, and apply sparingly either ointment in a thin film. For mild inflammations, use once daily to once a week. For severe conditions, apply initially two to three times daily, decreasing frequency as improvement occurs.
Limitations
Not intended for treatment of deep abscesses or deep-seated infections. Not for ophthalmic use. Federal law restricts this drug to use by or on the order of a licensed veterinarian.
Indication
For otic use. Use petrolatum base ointment for the treatment of acute and chronic otitis.
Dosage
Clean ear canal of impacted cerumen, remove any foreign bodies such as grass awns and ticks, and instill three to five drops of petrolatum base ointment. Preliminary use of a local anesthetic may be advisable. For mild inflammations, use once daily to once a week. For severe conditions, apply initially two to three times daily, decreasing frequency as improvement occurs.
Limitations
Not intended for treatment of deep abscesses or deep-seated infections. Not for ophthalmic use. Federal law restricts this drug to use by or on the order of a licensed veterinarian.
Indication
For cystic areas. Use petrolatum base ointment for the treatment of interdigital cysts.
Dosage
Drain cyst and fill with petrolatum base ointment. For mild inflammations, use once daily to once a week. For severe conditions, apply initially two to three times daily, decreasing frequency as improvement occurs.
Limitations
Not intended for treatment of deep abscesses or deep-seated infections. Not for ophthalmic use. Federal law restricts this drug to use by or on the order of a licensed veterinarian
Dogs
Indication
For infected anal glands and cystic areas. Use petrolatum base ointment for the treatment of interdigital cysts and for anal gland infections.
Dosage
Drain gland or cyst and fill with petrolatum base ointment. For mild inflammations, use once daily to once a week. For severe conditions, apply initially two to three times daily, decreasing frequency as improvement occurs.
Limitations
Not intended for treatment of deep abscesses or deep-seated infections. Not for ophthalmic use. Federal law restricts this drug to use by or on the order of a licensed veterinarian.
Indication
For topical dermatological use. Use either ointment for anti-inflammatory, antipruritic, antifungal, and antibacterial treatment of superficial bacterial infections, and for dermatologic disorders characterized by inflammation and dry or exudative dermatitis, particularly associated with bacterial or candidal (Candida albicans) infections.
Dosage
Clean affected areas and remove any encrusted discharge or exudate, and apply sparingly either ointment in a thin film. For mild inflammations, use once daily to once a week. For severe conditions, apply initially two to three times daily, decreasing frequency as improvement occurs.
Limitations
Not intended for treatment of deep abscesses or deep-seated infections. Not for ophthalmic use. Federal law restricts this drug to use by or on the order of a licensed veterinarian.
Indication
For otic use. Use petrolatum base ointment for the treatment of acute and chronic otitis.
Dosage
Clean ear canal of impacted cerumen, remove any foreign bodies such as grass awns and ticks, and instill three to five drops of petrolatum base ointment. Preliminary use of a local anesthetic may be advisable. For mild inflammations, use once daily to once a week. For severe conditions, apply initially two to three times daily, decreasing frequency as improvement occurs.
Limitations
Not intended for treatment of deep abscesses or deep-seated infections. Not for ophthalmic use. Federal law restricts this drug to use by or on the order of a licensed veterinarian.

FDA page: Open in Animal Drugs @ FDA

Species: Dog, No Use Class Stated Or Implied • Cat, No Use Class Stated Or Implied
Composition / specifications
Each milliliter of suspension contains 25 milligrams of neomycin sulfate equivalent to 17.5 milligrams of neomycin, 10,000 international units of penicillin G procaine, 5,000 international units of polymyxin B sulfate, 2 milligrams of hydrocortisone acetate, and 1.25 milligrams of hydrocortisone sodium succinate.
Dogs
Indication
Treatment of summer eczema, atopic dermatitis, interdigital eczema and otitis externa caused by bacteria susceptible to neomycin, penicillin, and polymyxin B.
Dosage
Rub a small amount into the involved area 1 to 3 times a day. After definite improvement, it may be applied once a day or every other day.
Limitations
For use in dogs only. Shake drug thoroughly and clean lesion before using. If redness, irritation, or swelling persists or increases, discontinue use and reevaluate diagnosis. Federal law restricts this drug to use by or on the order of a licensed veterinarian.

FDA page: Open in Animal Drugs @ FDA

Species: Dog, No Use Class Stated Or Implied
Composition / specifications
The drug is in tablet form. Each tablet contains both aminopropazine fumarate equivalent to 25 milligrams of aminopropazine base and neomycin sulfate equivalent to 50 milligrams of neomycin base.
Dogs
Indication
The drug is used in dogs to control bacterial diarrhea caused by organisms susceptible to neomycin and to reduce smooth muscle contractions.
Dosage
It is administered at a dosage level of one to two tablets per 10 pounds of body weight twice daily for 3 days.
Limitations
Federal law restricts this drug to use by or on the order of a licensed veterinarian.

FDA page: Open in Animal Drugs @ FDA

Species: Dog, No Use Class Stated Or Implied • Cat, No Use Class Stated Or Implied
Composition / specifications
Each milliliter of suspension contains 5 milligrams neomycin sulfate (equivalent to 3.5 milligrams neomycin base), 2 milligrams prednisolone, 5 milligrams tetracaine, and 0.25 milliliter squalane (hexamethyltetracosane).
Dogs
Indication
For treating acute otitis externa and as adjunctive therapy in management of chronic otitis externa. Also for treating moist dermatitis in dogs.
Dosage
2 to 3 applications daily or as needed.
Limitations
Tetracaine and neomycin have the potential to sensitize. If signs of irritation or sensitivity develop, discontinue use. Prolonged use of this product may result in overgrowth of non-susceptible organisms. If new infections due to bacteria or fungi appear during therapy, appropriate measures should be taken. Federal law restricts this drug to use by or on the order of a licensed veterinarian.
Cats
Indication
For treating acute otitis externa and as adjunctive therapy in management of chronic otitis externa.
Dosage
2 to 3 applications daily or as needed.
Limitations
Tetracaine and neomycin have the potential to sensitize. If signs of irritation or sensitivity develop, discontinue use. Prolonged use of this product may result in overgrowth of non-susceptible organisms. If new infections due to bacteria or fungi appear during therapy, appropriate measures should be taken. Federal law restricts this drug to use by or on the order of a licensed veterinarian.

FDA page: Open in Animal Drugs @ FDA

Species: Dog, No Use Class Stated Or Implied • Cat, No Use Class Stated Or Implied
Composition / specifications
Each gram contains 500 units of bacitracin, 3.5 milligrams of neomycin, and 10,000 units of polymyxin B.
Cats
Indication
Treatment of superficial bacterial infections of the eyelid and conjunctiva of cats when due to susceptible organisms.
Dosage
Apply a thin film over the cornea 3 or 4 times daily.
Limitations
Federal law restricts this drug to use by or on the order of a licensed veterinarian.
Dogs
Indication
Treatment of superficial bacterial infections of the eyelid and conjunctiva of dogs when due to susceptible organisms.
Dosage
Apply a thin film over the cornea 3 or 4 times daily.
Limitations
Federal law restricts this drug to use by or on the order of a licensed veterinarian.

FDA page: Open in Animal Drugs @ FDA

Species: Dog, No Use Class Stated Or Implied • Cat, No Use Class Stated Or Implied
Composition / specifications
The drug contains 5 milligrams of sulfate, equivalent to 3.5 milligrams of neomycin base, and 5 milligrams of hydrocortisone acetate in each gram of ointment.
Dogs
Indication
For treating infections, allergic, and traumatic keratitis, conjunctivitis, acute otitis externa and, to a lesser degree, chronic otitis externa in dogs.
Dosage
Apply three or four times daily into the conjunctival sac. With improvement, frequency may be reduced to two or three times daily. For treatment of ear canker and other inflammatory conditions of the external ear canal, fill external ear canal one to three times daily.
Limitations
All topical ophthalmic preparations containing corticosteroids, with or without an antimicrobial agent, are contraindicated in the initial treatment of corneal ulcers. They should not be used until infection is under control and corneal regeneration is well underway. Incomplete response or exacerbation of corticosteroid responsive lesions may be due to the presence of non-susceptible organisms or to prolonged use on antibiotic-containing preparations resulting in overgrowth of non-susceptible organisms, particularly Monilia. Federal law restricts this drug to use by or on the order of a licensed veterinarian.
Cats
Indication
For treating infections, allergic, and traumatic keratitis, conjunctivitis, acute otitis externa and, to a lesser degree, chronic otitis externa in cats.
Dosage
Apply three or four times daily into the conjunctival sac. With improvement, frequency may be reduced to two or three times daily. For treatment of ear canker and other inflammatory conditions of the external ear canal, fill external ear canal one to three times daily.
Limitations
All topical ophthalmic preparations containing corticosteroids, with or without an antimicrobial agent, are contraindicated in the initial treatment of corneal ulcers. They should not be used until infection is under control and corneal regeneration is well underway. Incomplete response or exacerbation of corticosteroid responsive lesions may be due to the presence of non-susceptible organisms or to prolonged use on antibiotic-containing preparations resulting in overgrowth of non-susceptible organisms, particularly Monilia. Federal law restricts this drug to use by or on the order of a licensed veterinarian.

FDA page: Open in Animal Drugs @ FDA

Species: Dog, No Use Class Stated Or Implied • Cat, No Use Class Stated Or Implied
Composition / specifications
The product contains 5 milligrams of neomycin sulfate, equivalent to 3.5 milligrams of neomycin base, 5 milligrams of hydrocortisone acetate, and 5 milligrams of tetracaine hydrochloride in each gram of ointment.
Dogs
Indication
It is indicated for treating acute otitis externa and, to a lesser degree, chronic otitis externa in dogs. In treatment of ear canker and other inflammatory conditions of the external ear canal.
Dosage
A quantity of ointment sufficient to fill the external ear canal may be applied one to three times daily.
Limitations
Tetracaine and neomycin have the potential to sensitize. Care should be taken to observe animals being treated for evidence of hypersensitivity or allergy to the product. If such signs are noted, therapy with the product should be stopped. Incomplete response or exacerbation of corticosteroid responsive lesions may be due to the presence of non susceptible organisms or to prolonged use of antibiotic-containing preparations resulting in overgrowth of non susceptible organisms, particularly Monilia. Federal law restricts this drug to use by or on the order of a licensed veterinarian.
Cats
Indication
It is indicated for treating acute otitis externa and, to a lesser degree, chronic otitis externa in cats. In treatment of ear canker and other inflammatory conditions of the external ear canal.
Dosage
A quantity of ointment sufficient to fill the external ear canal may be applied one to three times daily.
Limitations
Tetracaine and neomycin have the potential to sensitize. Care should be taken to observe animals being treated for evidence of hypersensitivity or allergy to the product. If such signs are noted, therapy with the product should be stopped. Incomplete response or exacerbation of corticosteroid responsive lesions may be due to the presence of non susceptible organisms or to prolonged use of antibiotic-containing preparations resulting in overgrowth of non susceptible organisms, particularly Monilia. Federal law restricts this drug to use by or on the order of a licensed veterinarian.

FDA page: Open in Animal Drugs @ FDA

Species: Dog, No Use Class Stated Or Implied
Composition / specifications
Each capsule contains 3.33 milligrams of prochlorperazine (as the dimaleate), 1.67 milligrams of isopropamide (as the iodide), and 25 milligrams of neomycin base (as the sulfate).
Dogs
Indication
For treatment of dogs in which infectious bacterial gastroenteritis is associated with emotional stress.
Dosage
10 to 20 pounds body weight- 1 capsule orally twice daily to dogs. 20 to 30 pounds body weight- 2 capsules orally twice daily to dogs. Over 30 pounds body weight- 3 capsules orally twice daily to dogs.
Limitations
Do not continue medication longer than 5 days. Overdosage or prolonged administration may produce nephrotoxicity as manifested by albuminuria, presence of granular casts and depressed urinary output. If it is desirable to administer a vasoconstrictor, norepinephrine is the drug of choice. Federal law restricts this drug to use by or on the order of a licensed veterinarian.

FDA page: Open in Animal Drugs @ FDA

Species: Dog, No Use Class Stated Or Implied • Cat, No Use Class Stated Or Implied
Composition / specifications
Prednisolone acetate-neomycin sulfate sterile suspension contains 2.5 milligrams of prednisolone acetate and 5 milligrams of neomycin sulfate (equivalent to 3.5 milligrams of neomycin base) in each milliliter of sterile suspension
Dogs
Indication
The drug is indicated for treating infectious allergic and traumatic keratitis and conjunctivitis, otitis externa, and chronic otitis externa in dogs.
Dosage
For beginning treatment of acute ocular inflammations 1 or 2 drops may be placed in the conjunctival sac 3 to 6 times during a 24 hour period. When improvement occurs, the dosage may be reduced to 1 drop 2 to 4 times daily. In otitis externa, 2 to 6 drops may be placed in the external ear canal 2 or 3 times daily.
Limitations
All topical ophthalmic preparations containing corticosteroids with or without an anti-microbial agent are contraindicated in the initial treatment of corneal ulcers. They should not be used until infection is under control and corneal regeneration is well underway. Federal law restricts this drug to use by or on the order of a licensed veterinarian.
Cats
Indication
The drug is indicated for treating infectious allergic and traumatic keratitis and conjunctivitis, otitis externa, and chronic otitis externa in cats.
Dosage
For beginning treatment of acute ocular inflammations 1 or 2 drops may be placed in the conjunctival sac 3 to 6 times during a 24 hour period. When improvement occurs, the dosage may be reduced to 1 drop 2 to 4 times daily. In otitis externa, 2 to 6 drops may be placed in the external ear canal 2 or 3 times daily.
Limitations
All topical ophthalmic preparations containing corticosteroids with or without an anti-microbial agent are contraindicated in the initial treatment of corneal ulcers. They should not be used until infection is under control and corneal regeneration is well underway. Federal law restricts this drug to use by or on the order of a licensed veterinarian.

FDA page: Open in Animal Drugs @ FDA

Species: Dog, No Use Class Stated Or Implied • Cat, No Use Class Stated Or Implied
Composition / specifications
Each gram of the ointment contains 5 milligrams of neomycin sulfate equivalent in activity to 3.5 milligrams of neomycin base.
Dogs
Indication
The drug is intended for use in dogs for the treatment of superficial ocular bacterial infections limited to the conjunctival or the anterior segment of the eye.
Dosage
The drug is applied four times each day.
Limitations
Federal law restricts this drug to use by or on the order of a licensed veterinarian.
Cats
Indication
The drug is intended for use in cats for the treatment of superficial ocular bacterial infections limited to the conjunctival or the anterior segment of the eye.
Dosage
The drug is applied four times each day.
Limitations
Federal law restricts this drug to use by or on the order of a licensed veterinarian.

FDA page: Open in Animal Drugs @ FDA

Species: Dog, No Use Class Stated Or Implied • Cat, No Use Class Stated Or Implied
Composition / specifications
Each gram contains 400 units of bacitracin zinc, 3.5 milligrams of neomycin, and 10,000 units of polymyxin B.
Cats
Indication
Treatment of superficial bacterial infections of the eyelid and conjunctiva of cats when due to susceptible organisms.
Dosage
Apply a thin film over the cornea three or four times daily.
Limitations
Federal law restricts this drug to use by or on the order of a licensed veterinarian.
Dogs
Indication
Treatment of superficial bacterial infections of the eyelid and conjunctiva of dogs when due to susceptible organisms.
Dosage
Apply a thin film over the cornea three or four times daily.
Limitations
Federal law restricts this drug to use by or on the order of a licensed veterinarian.

FDA page: Open in Animal Drugs @ FDA

Species: Dog, No Use Class Stated Or Implied • Cat, No Use Class Stated Or Implied
Composition / specifications
The drug contains 0.025 percent fluocinolone acetonide and 0.5 percent neomycin sulfate (0.35 percent neomycin base).
Dogs
Indication
The drug is used in the relief of pruritus and inflammation associated with superficial acute and chronic dermatoses in dogs. It is used in the treatment of such conditions as allergic and acute moist dermatoses and nonspecific dermatoses in dogs. It is used in the treatment of wound infections in dogs.
Dosage
A small amount is applied to the infected area two or three times daily.
Limitations
Federal law restricts this drug to use by or on the order of a licensed veterinarian.
Cats
Indication
It is used in the treatment of wound infections in cats.
Dosage
A small amount is applied to the infected area two or three times daily.
Limitations
Federal law restricts this drug to use by or on the order of a licensed veterinarian.

FDA page: Open in Animal Drugs @ FDA

Species: Dog, No Use Class Stated Or Implied
Composition / specifications
Each milliliter of the ophthalmic preparation contains 5.0 milligrams neomycin sulfate (3.5 milligrams neomycin base), and 10,000 Units of polymyxin B sulfate.
Dogs
Indication
For the treatment of bacterial infections associated with topical ophthalmological conditions such as corneal injuries, superficial keratitis, conjunctivitis, keratoconjunctivitis, and blepharitis.
Dosage
Instill 1 to 2 drops per eye every 6 hours.
Limitations
Federal law restricts this drug to use by or on the order of a licensed veterinarian.

FDA page: Open in Animal Drugs @ FDA

Species: Dog, No Use Class Stated Or Implied • Cat, No Use Class Stated Or Implied
Composition / specifications
Each milliliter of petrolatum base or each gram of vanishing cream base ointment contains: 100,000 units of nystatin; neomycin sulfate equivalent to 2.5 milligrams of neomycin base; 2,500 units of thiostrepton; and 1.0 milligram of triamcinolone acetonide.
Cats
Indication
Topically: Use either ointment in dogs and cats for anti-inflammatory, antipruritic, antifungal, and antibacterial treatment of superficial bacterial infections, and for dermatologic disorders characterized by inflammation and dry or exudative dermatitis, particularly associated with bacterial or candidal (Candida albicans) infections.
Dosage
For topical dermatological use: Clean affected areas and remove any encrusted discharge or exudate, and apply sparingly either ointment in a thin film.
Limitations
For mild inflammations, use once daily to once a week. For severe conditions, apply initially two to three times daily, decreasing frequency as improvement occurs. Not intended for treatment of deep abscesses or deep-seated infections. Not for ophthalmic use. Federal law restricts this drug to use by or on the order of a licensed veterinarian.
Dogs
Indication
Topically: Use either ointment in dogs and cats for anti-inflammatory, antipruritic, antifungal, and antibacterial treatment of superficial bacterial infections, and for dermatologic disorders characterized by inflammation and dry or exudative dermatitis, particularly associated with bacterial or candidal (Candida albicans) infections.
Dosage
For topical dermatological use: Clean affected areas and remove any encrusted discharge or exudate, and apply sparingly either ointment in a thin film.
Limitations
For mild inflammations, use once daily to once a week. For severe conditions, apply initially two to three times daily, decreasing frequency as improvement occurs. Not intended for treatment of deep abscesses or deep-seated infections. Not for ophthalmic use. Federal law restricts this drug to use by or on the order of a licensed veterinarian.

FDA page: Open in Animal Drugs @ FDA

Species: Dog, No Use Class Stated Or Implied • Cat, No Use Class Stated Or Implied
Composition / specifications
Each milliliter of petrolatum base or each gram of vanishing cream base ointment contains: 100,000 units of nystatin; neomycin sulfate equivalent to 2.5 milligrams of neomycin base; 2,500 units of thiostrepton; and 1.0 milligram of triamcinolone acetonide.
Cats
Indication
Otitis and cysts: Use petrolatum base ointment in cats for the treatment of acute and chronic otitis and interdigital cysts.
Dosage
For otic use: Clean ear canal of impacted cerumen, remove any foreign bodies such as grass awns and ticks, and instill three to five drops of petrolatum base ointment. Preliminary use of a local anesthetic may be advisable. For cystic areas: Drain gland or cyst and fill with petrolatum base ointment.
Limitations
For mild inflammations, use once daily to once a week. For severe conditions, apply initially two to three times daily, decreasing frequency as improvement occurs. Not intended for treatment of deep abscesses or deep-seated infections. Not for ophthalmic use. Federal law restricts this drug to use by or on the order of a licensed veterinarian.
Indication
Topically: Use either ointment in cats for anti-inflammatory, antipruritic, antifungal, and antibacterial treatment of superficial bacterial infections, and for dermatologic disorders characterized by inflammation and dry or exudative dermatitis, particularly associated with bacterial or candidal (Candida albicans) infections.
Dosage
For topical dermatological use: Clean affected areas and remove any encrusted discharge or exudate, and apply sparingly either ointment in a thin film.
Limitations
For mild inflammations, use once daily to once a week. For severe conditions, apply initially two to three times daily, decreasing frequency as improvement occurs. Not intended for treatment of deep abscesses or deep-seated infections. Not for ophthalmic use. Federal law restricts this drug to use by or on the order of a licensed veterinarian.
Dogs
Indication
Otitis, cysts, and anal gland infections: Use petrolatum base ointment in dogs for the treatment of acute and chronic otitis and interdigital cysts, and in dogs for anal gland infections.
Dosage
For otic use: Clean ear canal of impacted cerumen, remove any foreign bodies such as grass awns and ticks, and instill three to five drops of petrolatum base ointment. Preliminary use of a local anesthetic may be advisable. For infected anal glands and cystic areas: Drain gland or cyst and fill with petrolatum base ointment.
Limitations
For mild inflammations, use once daily to once a week. For severe conditions, apply initially two to three times daily, decreasing frequency as improvement occurs. Not intended for treatment of deep abscesses or deep-seated infections. Not for ophthalmic use. Federal law restricts this drug to use by or on the order of a licensed veterinarian.
Indication
Topically: Use either ointment in dogs for anti-inflammatory, antipruritic, antifungal, and antibacterial treatment of superficial bacterial infections, and for dermatologic disorders characterized by inflammation and dry or exudative dermatitis, particularly associated with bacterial or candidal (Candida albicans) infections.
Dosage
For topical dermatological use: Clean affected areas and remove any encrusted discharge or exudate, and apply sparingly either ointment in a thin film.
Limitations
For mild inflammations, use once daily to once a week. For severe conditions, apply initially two to three times daily, decreasing frequency as improvement occurs. Not intended for treatment of deep abscesses or deep-seated infections. Not for ophthalmic use. Federal law restricts this drug to use by or on the order of a licensed veterinarian.

FDA page: Open in Animal Drugs @ FDA

Species: Dog, No Use Class Stated Or Implied • Cat, No Use Class Stated Or Implied
Composition / specifications
Each milliliter of solution contains 40 milligrams (mg) thiabendazole, 3.2 mg neomycin (from neomycin sulfate), and 1 mg dexamethasone.
Label highlights
Indication
As an aid in the treatment of bacterial, mycotic, and inflammatory dermatoses and otitis externa
Dosage
In treating dermatoses affecting areas other than the ear, the surface of the lesions should be well moistened (2 to 4 drops per square inch) twice daily. In treating otitis externa, instill 5 to 15 drops in the ear twice daily. Treat for up to 7 days
Limitations
Federal law restricts this drug to use by or on the order of a licensed veterinarian

FDA page: Open in Animal Drugs @ FDA

Species: Dog, No Use Class Stated Or Implied • Cat, No Use Class Stated Or Implied
Composition / specifications
Each cubic centimeter of neomycin sulfate-thiabendazole-dexamethasone solution contains: 40 milligrams of thiabendazole, 3.2 milligrams of neomycin (from neomycin sulfate), and 1 milligram of dexamethasone.
Cats
Indication
The drug is recommended for use as an aid in the treatment of bacterial, mycotic, and inflammatory dermatoses and otitis externa in cats.
Dosage
In treating dermatoses affecting areas other than the ear, the surface of the lesions should be well moistened (two to four drops per square inch) twice daily. In treating otitis externa, five to 15 drops of the drug should be instilled in the ear twice daily. The is limited to 7 days maximum duration of administration.
Limitations
For use only by or on order of a licensed veterinarian.
Dogs
Indication
The drug is recommended for use as an aid in the treatment of bacterial, mycotic, and inflammatory dermatoses and otitis externa in dogs.
Dosage
In treating dermatoses affecting areas other than the ear, the surface of the lesions should be well moistened (two to four drops per square inch) twice daily. In treating otitis externa, five to 15 drops of the drug should be instilled in the ear twice daily. The is limited to 7 days maximum duration of administration.
Limitations
For use only by or on order of a licensed veterinarian.

FDA page: Open in Animal Drugs @ FDA

Species: Dog, No Use Class Stated Or Implied • Horse, No Use Class Stated Or Implied • Cat, No Use Class Stated Or Implied
Composition / specifications
The drug contains 5 milligrams of neomycin sulfate (equivalent to 3.5 milligrams of neomycin base), 1 milligram of isoflupredone acetate, and 5 milligrams of tetracaine hydrochloride in each gram of ointment.
Horses
Indication
A useful dressing for minor cuts, lacerations, abrasions, and post-surgical therapy in the horse. It may also be used following amputation of dewclaw, tails and claws, following ear trimming and castrating operations.
Dosage
When used on the skin or mucous membranes, the affected area should be cleansed, and a small amount of the ointment applied and spread or rubbed in gently. The involved area may be treated one to three times a day and these daily applications continued in accordance with the clinical response.
Limitations
Federal law restricts this drug to use by or on the order of a licensed veterinarian.
Dogs
Indication
It is used in treating such conditions as acute otitis externa in dogs and to a lesser degree, chronic otitis externa in dogs. It also is effective in treating anal gland infections and moist dermatitis in the dog and is a useful dressing for minor cuts, lacerations, abrasions, and post-surgical therapy in the dog. It may also be used following amputation of dewclaw, tails and claws, following ear trimming and castrating operations.
Dosage
In treatment of otitis externa and other inflammatory conditions of the external ear canal a quantity of ointment sufficient to fill the external ear canal may be applied one to three times daily. When used on the skin or mucous membranes, the affected area should be cleansed, and a small amount of the ointment applied and spread or rubbed in gently. The involved area may be treated one to three times a day and these daily applications continued in accordance with the clinical response.
Limitations
Federal law restricts this drug to use by or on the order of a licensed veterinarian.
Cats
Indication
A useful dressing for minor cuts, lacerations, abrasions, and post-surgical therapy in the cat. It may also be used following amputation of dewclaw, tails and claws, following ear trimming and castrating operations.
Dosage
When used on the skin or mucous membranes, the affected area should be cleansed, and a small amount of the ointment applied and spread or rubbed in gently. The involved area may be treated one to three times a day and these daily applications continued in accordance with the clinical response.
Limitations
Federal law restricts this drug to use by or on the order of a licensed veterinarian.

FDA page: Open in Animal Drugs @ FDA

Species: Dog, No Use Class Stated Or Implied • Cat, No Use Class Stated Or Implied
Composition / specifications
Each gram of ointment contains 400 units of bacitracin zinc, 10,000 units of polymyxin B sulfate, 5 milligrams of neomycin sulfate (equivalent to 3.5 milligrams of neomycin base), and 10 milligrams of hydrocortisone acetate.
Cats
Indication
Treating acute or chronic conjunctivitis caused by susceptible organisms.
Dosage
Apply a thin film over the cornea three or four times daily.
Limitations
Federal law restricts this drug to use by or on the order of a licensed veterinarian.
Dogs
Indication
Treating acute or chronic conjunctivitis caused by susceptible organisms.
Dosage
Apply a thin film over the cornea three or four times daily.
Limitations
Federal law restricts this drug to use by or on the order of a licensed veterinarian.

FDA page: Open in Animal Drugs @ FDA

Official Documents (FDA)

Direct links to FDA-hosted PDFs and SPL packages (when available).

Documents
  • Summary
    Provides for the finalization of NAS/NRC/DESI review of Neomycin Sulfate Type A Medicated Articles.
SPL Packages

FDA page: Open in Animal Drugs @ FDA

Documents
  • Summary
    Provides for the use of neomycin sulfate (NEOMIX®325Soluble Powder/NEOMIX® AG 325 Soluble Powder/NEOMIX® AG 325 Soluable Powder) in growing turkeys for the control of mortality associted with Escherichia coli organisms sussceptible to neomycin sulfate.
  • Summary

    To increase the tolerance in the target tissue, kidneys, to 7.2 ppm and to decrease the withdrawal periods to 1 day in cattle, 2 days in sheep, and 3 days for swine and goats.

  • Summary
    The effectiveness neomycin sulfate was reviewed by the National Academy of Sciences/National Research Council Drug Efficacy Study Implementation (NAS/NRC DESI) and has been deemed effective when labeled as specified in the Indications and Recommended Dosage section of the summary.
  • EA 011-315
  • FONSI 011-315
  • EA 011-315
  • FONSI 011-315
SPL Packages

FDA page: Open in Animal Drugs @ FDA

Documents
  • Summary

    Panavet Ointment (nystatin, neomycin sulfate, thiostrepton, triamcinolone acetonide ointment) is particularly useful in the treatment of acute and chronic otitis of varied etiologies, in interdigital cysts in cats and dogs, and in anal gland infections in dogs. 

    The preparation is also indicated in the management of dermatologic disorders characterized by inflammation and dry or exudative dermatitis, particularly those caused, complicated, or threatened by bacterial or candidal (Candida albicans) infections. It is also of value in eczematous dermatitis, contact dermatitis, and seborrheic dermatitis, and as an adjunct in the treatment of dermatitis due to parasitic infestation.

SPL Packages

FDA page: Open in Animal Drugs @ FDA

Documents
  • Summary

    To increase the tolerance in the target tissue, kidneys, to 7.2 ppm and to decrease the withdrawal periods to 1 day in cattle, 2 days in sheep, and 3 days for swine and goats.

  • Summary

    For the treatment and control of colibacillosis (bacterial enteritis) caused by Escherichia coli susceptible to neomycin sulfate in cattle (excluding veal calves), swine, sheep, and goats.

SPL Packages

FDA page: Open in Animal Drugs @ FDA

Documents
  • Summary
    Derma-Vet Cream is indicated in the management of dermatologic disorders in dogs and cats, characterized by inflammation and dry or exudative dermatitis, particularly those caused, complicated or threatened by bacterial or candidal (Candida albicans) infections. It is also of value in eczematous dermatitis, contact dermatitis and seborrheic dermatitis; and as an adjunct in the treatment of dermatitis due to parasitic infestation.
SPL Packages

FDA page: Open in Animal Drugs @ FDA

Documents
  • Summary
    For the treatment and control of colibacillosis (bacterial enteritis) caused by Escherichia coli susceptible to neomycin sulfate.
SPL Packages

FDA page: Open in Animal Drugs @ FDA

Documents
  • Summary
    For the treatment of superficial bacterial infections of the eyelid and conjunctiva of dogs and cats when due to organisms susceptible to one or more of the antibiotics contained in the ointment.
SPL Packages

FDA page: Open in Animal Drugs @ FDA

SPL Packages

FDA page: Open in Animal Drugs @ FDA

Documents
  • Summary
    This supplement provides for use of the addition of a new species, turkeys..
  • Summary

    To increase the tolerance in the target tissue, kidneys, to 7.2 ppm and to decrease the withdrawal periods to 1 day in cattle, 2 days in sheep, and 3 days for swine and goats.

  • Summary

    For the treatment and control of colibacillosis (bacterial enteritis) caused by Escherichia coli susceptible to neomycin sulfate.

SPL Packages

FDA page: Open in Animal Drugs @ FDA

Documents
  • Summary

    Topical dermatologic disorders characterized by inflammation and dry or exudative dermatitis, particularly associated with bacterial or candidal infections.

SPL Packages

FDA page: Open in Animal Drugs @ FDA

Documents
  • Summary

    To revise the withdrawal period to 1 day in cattle 2 days in sheep, and 3 days for swine and goats to be identical to pioneer product.

  • Summary

    For the treatment and control of colibacillosis (bacterial enteritis) caused by Escherichia coli susceptible to neomycin sulfate.

SPL Packages

FDA page: Open in Animal Drugs @ FDA

Documents
  • Summary

    For the treatment and control of colibacillosis (bacterial enteritis) caused by Escherichia coli susceptible to neomycin sulfate.

SPL Packages

FDA page: Open in Animal Drugs @ FDA

Documents
  • Summary

    For treatment and control of colibacillosis (bacterial enteritis) caused by Escherichia coli susceptible to neomycin sulfate.

SPL Packages

FDA page: Open in Animal Drugs @ FDA

Documents
  • Summary

    Changes withdrawal times and tolerance information.

  • Summary

    For the treatment and control of colibacillosis (bacterial enteritis) caused by Escherichia coli susceptible to neomycin sulfate.

SPL Packages

FDA page: Open in Animal Drugs @ FDA

Documents
  • Summary

    Animax Ointment (nystatin, neomycin sulfate, thiostrepton, triamcinolone acetonide ointment) is particularly useful in the treatment of acute and chronic otitis of varied etiologies, in interdigital cysts in cats and dogs, and in anal gland infections in dogs. 

    The preparation is also indicated in the management of dermatologic disorders characterized by inflammation and dry or exudative dermatitis, particularly those caused, complicated, or threatened by bacterial or candidal (Candida albicans) infections. It is also of value in eczematous dermatitis, contact dermatitis, and seborrheic dermatitis, and as an adjunct in the treatment of dermatitis due to parasitic infestation. 

SPL Packages

FDA page: Open in Animal Drugs @ FDA

Documents
  • Summary

    DERMA 4 Ointment is particularly useful in the treatment of:

    1.  acute and chronic otitis of varied etiologies;
    2. interdigital cysts in dogs and cat; 
    3. anal gland infections in dogs;  
    4. dermatologic disorders characterized by inflammation and dry or exudative dermatitis, particularly those caused, complicated, or threatened by bacterial or candidal (Candida albicans) infection; and
    5. eczematous, contact and seborrheic dermatitis.

    Additionally, DERMA 4 Ointment may be used as an adjunct in the treatment of dermatitis due to parasitic infestation.


SPL Packages

FDA page: Open in Animal Drugs @ FDA

Documents
  • Summary
    For the treatment and control of colibacillosis (bacterial enteritis) caused by Escherichia coli susceptible to neomycin sulfate in cattle, swine, sheep, and goats.
SPL Packages

FDA page: Open in Animal Drugs @ FDA

Documents
  • Summary
    For the treatment and control of colibacillosis (bacterial enteritis) caused by Escherichia coli susceptible to neomycin sulfate. For the control of mortality associated with Escherichia coli organisms susceptible to neomycin sulfate in growing turkeys.
SPL Packages

FDA page: Open in Animal Drugs @ FDA

Documents
  • Summary
    This supplemental application provides for use in an additional species, growing turkeys.
SPL Packages

FDA page: Open in Animal Drugs @ FDA

SPL Packages

FDA page: Open in Animal Drugs @ FDA

SPL Packages

FDA page: Open in Animal Drugs @ FDA

SPL Packages

FDA page: Open in Animal Drugs @ FDA

SPL Packages

FDA page: Open in Animal Drugs @ FDA

SPL Packages

FDA page: Open in Animal Drugs @ FDA

SPL Packages

FDA page: Open in Animal Drugs @ FDA

SPL Packages

FDA page: Open in Animal Drugs @ FDA

SPL Packages

FDA page: Open in Animal Drugs @ FDA

Documents
  • Summary
    As an aid in the treatment of certain bacterial, mycotic, and inflammatory dermatoses and otitis externa in dogs and cats.
SPL Packages

FDA page: Open in Animal Drugs @ FDA

Usage

It is indicated for treating acute otitis externa and, to a lesser degree, chronic otitis externa in dogs. In treatment of ear canker and other inflammatory conditions of the external ear canal. It is indicated for treating acute otitis externa and, to a lesser degree, chronic otitis externa in cats. In treatment of ear canker and other inflammatory conditions of the external ear canal. For the treatment and control of colibacillosis (bacterial enteritis) caused by Escherichia coli susceptible to neomycin sulfate in cattle.

Source: FDA Animal Drugs @ FDA • Reference

Contraindications

Tetracaine and neomycin have the potential to sensitize. Care should be taken to observe animals being treated for evidence of hypersensitivity or allergy to the product. If such signs are noted, therapy with the product should be stopped. Incomplete response or exacerbation of corticosteroid responsive lesions may be due to the presence of non susceptible organisms or to prolonged use of antibiotic-containing preparations resulting in overgrowth of non susceptible organisms, particularly Monilia. Federal law restricts this drug to use by or on the order of a licensed veterinarian. Add to drinking water. Not for use in liquid supplements. Prepare a fresh solution daily. If symptoms persist after using this preparation for 2 or 3 days, consult a veterinarian. Treatment should continue 24-48 hours beyond remission of disease symptoms, but not to exceed a total of 14 days. Discontinue treatment 1 day prior to slaughter in cattle. A withdrawal period has not been established for use in preruminating calves. Do not use in calves to be processed for veal. Use of more than one product containing neomycin or failure to follow withdrawal times may result in illegal drug residues. Add to drinking water. Not for use in liquid supplements. Prepare a fresh solution daily. If symptoms persist after using this preparation for 2 or 3 days, consult a veterinarian. Treatment should continue 24-48 hours beyond remission of disease symptoms, but not to exceed a total of 14 days. Discontinue treatment 2 days prior to slaughter in sheep. Use of more than one product containing neomycin or failure to follow withdrawal times may result in illegal drug residues.

Side Effects

No approved side-effect narrative is linked yet.

openFDA reaction signals are available for Dog 8 and Cat 56 (view top reported reactions).

Top Reported Reactions (openFDA)

Aggregated reaction terms from FDA openFDA reports (not verified; does not prove causation).

Dog
Digestive
Vomiting (12)
Neurologic
Tiredness (lethargy) (17)
Effectiveness
Lack of efficacy - NOS (13)
Other
Loss of hearing (16) Deafness (13) Pinnal erythema (10) Drug administration duration too long (9) Other abnormal test result NOS (9)
Cat
Digestive
Vomiting (58) Loss of appetite (32) Decreased appetite (1) Decreased appetite (1) Decreased appetite (1) Decreased appetite (1) Decreased appetite (1) Decreased appetite (1) Loss of appetite (1) Loss of appetite (1) Loss of appetite (1) Loss of appetite (1) Loss of appetite (1) Loss of appetite (1)
Neurologic
Tiredness (lethargy) (55) Tiredness (lethargy) (45) Unsteady walking (ataxia) (32) Tiredness (lethargy) (5) Tiredness (lethargy) (5) Tiredness (lethargy) (5) Tiredness (lethargy) (5) Tiredness (lethargy) (5) Tiredness (lethargy) (4) Unsteady walking (ataxia) (1) Unsteady walking (ataxia) (1) Unsteady walking (ataxia) (1) Unsteady walking (ataxia) (1) Unsteady walking (ataxia) (1) Unsteady walking (ataxia) (1)
Effectiveness
Lack of efficacy - NOS (31)
Other
Not eating (45) Elevated alanine aminotransferase (41) Abnormal cytology (1) Abnormal cytology (1) Abnormal cytology (1) Abnormal cytology (1) Abnormal cytology (1) Abnormal cytology (1) Abnormal radiograph finding (1) Abnormal radiograph finding (1) Abnormal radiograph finding (1) Abnormal radiograph finding (1) Abnormal radiograph finding (1) Abnormal radiograph finding (1) Fever (1) Fever (1) Fever (1) Fever (1) Fever (1) Increased drinking (1) Increased drinking (1) Increased drinking (1) Increased drinking (1) Increased drinking (1) Increased drinking (1) Loss of hearing (1)

Data source: FDA openFDA Animal & Veterinary adverse event reports.

Adverse Event Case Summaries (openFDA)

These are individual FDA adverse event reports. They are unverified and do not prove the medication caused the reaction.

Cat, Domestic Shorthair, Male, 3 year, 5.65 kilogram • Drug: MSK, Topical, Dose: 6 drops per animal, Frequency: 12 per hour • Reactions: Tiredness (lethargy), Vomiting, Otitis media, Tympanic alteration, Abnormal radiograph finding… • Outcome: Ongoing

  • Report ID: USA-USFDACVM-2025-US-056132
  • Serious AE: No
  • Treated For AE: Yes
  • Sex: Male
  • Age: 3.00 Year
  • Weight: 5.650 Kilogram
  • Case-reported brand: MSK
  • Case-reported manufacturer: MSK
  • Route: Topical
  • Dose: 6 drops per animal
  • Frequency: 12 per hour
Reactions Reported:
Tiredness (lethargy) Vomiting Otitis media Tympanic alteration Abnormal radiograph finding Not eating Abnormal cytology
Outcomes: Ongoing

Cat, Cat (unknown), Unknown • Drug: MSK, Unknown • Reactions: Increased drinking, Reluctant to move, Tiredness (lethargy) • Outcome: Recovered/Normal

  • Report ID: USA-USFDACVM-2025-US-054681
  • Serious AE: No
  • Treated For AE: No
  • Sex: Unknown
  • Case-reported brand: MSK
  • Case-reported manufacturer: MSK
  • Route: Unknown
Reactions Reported:
Increased drinking Reluctant to move Tiredness (lethargy)
Outcomes: Recovered/Normal

Cat, American Shorthair, Female, 6 year, 4.781 kilogram • Drug: MSK, Auricular (Otic), Dose: 6 drops per animal, Frequency: 12 per hour • Reactions: Unsteady walking (ataxia), Loss of appetite, Nystagmus • Outcome: Outcome Unknown

  • Report ID: USA-USFDACVM-2025-US-054206
  • Serious AE: No
  • Treated For AE: Yes
  • Sex: Female
  • Age: 6.00 Year
  • Weight: 4.781 Kilogram
  • Case-reported brand: MSK
  • Case-reported manufacturer: MSK
  • Route: Auricular (Otic)
  • Dose: 6 drops per animal
  • Frequency: 12 per hour
Reactions Reported:
Unsteady walking (ataxia) Loss of appetite Nystagmus
Outcomes: Outcome Unknown

Cat, Domestic Shorthair, Male, 8 year, 6.713 kilogram • Drug: MSK, Auricular (Otic) • Reactions: Tiredness (lethargy), Decreased appetite • Outcome: Ongoing

  • Report ID: USA-USFDACVM-2025-US-055591
  • Serious AE: No
  • Treated For AE: No
  • Sex: Male
  • Age: 8.00 Year
  • Weight: 6.713 Kilogram
  • Case-reported brand: MSK
  • Case-reported manufacturer: MSK
  • Route: Auricular (Otic)
Reactions Reported:
Tiredness (lethargy) Decreased appetite
Outcomes: Ongoing

Cat, British cat, Female, 18 month, 3.311 kilogram • Drug: MSK, Auricular (Otic), Dose: 5 drops per animal • Reactions: Loss of hearing • Outcome: Outcome Unknown

  • Report ID: USA-USFDACVM-2025-US-052431
  • Serious AE: Yes
  • Treated For AE: No
  • Sex: Female
  • Age: 18.00 Month
  • Weight: 3.311 Kilogram
  • Case-reported brand: MSK
  • Case-reported manufacturer: MSK
  • Route: Auricular (Otic)
  • Dose: 5 drops per animal
Reactions Reported:
Loss of hearing
Outcomes: Outcome Unknown

Dog, Poodle - Toy, Male, 11 year, 4.08 kilogram • Drug: MSK, Unknown • Reactions: Diarrhea, Circling - neurological disorder, Inappropriate urination, Bumping into walls, Inappropriate defecation… • Outcome: Ongoing

  • Report ID: USA-USFDACVM-2025-US-047828
  • Serious AE: Yes
  • Treated For AE: No
  • Sex: Male
  • Age: 11.00 Year
  • Weight: 4.080 Kilogram
  • Case-reported brand: MSK
  • Case-reported manufacturer: MSK
  • Route: Unknown
Reactions Reported:
Diarrhea Circling - neurological disorder Inappropriate urination Bumping into walls Inappropriate defecation Cataract Dental plaque Walking difficulty Corneal disorder NOS Musculoskeletal pain Musculoskeletal disorder NOS
Outcomes: Ongoing

Dog, Rottweiler, Female, 3 year, 42.41 kilogram • Drug: MSK • Reactions: Ear discharge • Outcome: Recovered/Normal

  • Report ID: USA-USFDACVM-2025-US-046347
  • Serious AE: No
  • Treated For AE: No
  • Sex: Female
  • Age: 3.00 Year
  • Weight: 42.410 Kilogram
  • Case-reported brand: MSK
  • Case-reported manufacturer: MSK
Reactions Reported:
Ear discharge
Outcomes: Recovered/Normal

Dog, ['Poodle (unspecified)', 'Retriever - Golden'], Male, 4 year, 29.71 kilogram • Drug: MSK • Reactions: Head shake - ear disorder, Ear pain • Outcome: Outcome Unknown

  • Report ID: USA-USFDACVM-2025-US-043546
  • Serious AE: No
  • Treated For AE: No
  • Sex: Male
  • Age: 4.00 Year
  • Weight: 29.710 Kilogram
  • Case-reported brand: MSK
  • Case-reported manufacturer: MSK
Reactions Reported:
Head shake - ear disorder Ear pain
Outcomes: Outcome Unknown

Data source: FDA openFDA Animal & Veterinary adverse event reports.

Overdose Information

No approved overdose-management text is linked yet. If overdose is suspected, contact a veterinarian or emergency clinic immediately.

Storage & Handling

No approved storage guidance is linked yet for this ingredient. Use manufacturer packaging and veterinary guidance for handling/storage.

Share Your Thoughts

Let others know your experience or advice regarding this medication.

This medication has not been reviewed by a veterinarian yet.